Human Herpesvirus 2 (HSV-2)

  HSV-2 References  
  1. Ackermann G, Ackermann F, Eggers HJ, Wieland U, Kuhn JE. 1998. Mapping of linear antigenic determinants on glycoprotein C of herpes simplex virus type 1 and type 2 recognized by human serum immunoglobulin G antibodies. J Med Virol. 1998 Aug;55(4):281-7. PMID: 9661836.
  2. Alanen A, Hukkanen V. 2000. Herpes simplex virus DNA in amniotic fluid without neonatal infection. Clin Infect Dis. 2000 Feb;30(2):363-7. PMID: 10671342.
  3. Albin R, Chase R, Risano C, Lieberman M, Ferrari E, Skelton A, Buontempo P, Cox S, DeMartino J, Wright-Minogue J, Jirau-Lucca G, Kelly J, Afonso A, Kwong AD, Rozhon EJ, O'Connell JF. 1997. SCH 43478 and analogs: in vitro activity and in vivo efficacy of novel agents for herpesvirus type 2. Antiviral Res. 1997 Aug;35(3):139-46. PMID: 9298753.
  4. Aono T, Murakami S, Yanagihara N, Yamanishi K. 1994. Detection of human alpha-herpesvirus DNA using consensus primers and specific probes. Acta Otolaryngol Suppl. 1994;514:132-4. PMID: 8073876.
  5. Arsenakis M, Campadelli-Fiume G, Roizman B. 1988. Regulation of glycoprotein D synthesis: does alpha 4, the major regulatory protein of herpes simplex virus 1, regulate late genes both positively and negatively? J Virol. 1988 Jan;62(1):148-58. PMID: 2824843.
  6. Arsenakis M, Hubenthal-Voss J, Campadelli-Fiume G, Pereira L, Roizman B. 1986. Construction and properties of a cell line constitutively expressing the herpes simplex virus glycoprotein B dependent on functional alpha 4 protein synthesis. J Virol. 1986 Nov;60(2):674-82. PMID: 3022001.
  7. Arvin AM, Prober CG. 1993. Analysis of the epidemiology and pathogenesis of herpes simplex virus (HSV) infections in pregnant women and infants using the HSV-2 glycoprotein G antibody assay. Infect Agents Dis. 1993 Dec;2(6):375-82. Review. No abstract available. PMID: 8012738.
  8. Asano S, Honda T, Goshima F, Nishiyama Y, Sugiura Y. 2000. US3 protein kinase of herpes simplex virus protects primary afferent neurons from virus-induced apoptosis in ICR mice. Neurosci Lett. 2000 Nov 17;294(2):105-8. PMID: 11058798.
  9. Ashley R, Benedetti J, Corey L. 1985. Humoral immune response to HSV-1 and HSV-2 viral proteins in patients with primary genital herpes. J Med Virol. 1985 Oct;17(2):153-66. PMID: 2997384.
  10. Ashley R, Mertz GJ, Corey L. 1987. Detection of asymptomatic herpes simplex virus infections after vaccination. J Virol. 1987 Feb;61(2):264-8. PMID: 3806788.
  11. Ashley RL, Eagleton M, Pfeiffer N. 1999. Ability of a rapid serology test to detect seroconversion to herpes simplex virus type 2 glycoprotein G soon after infection. J Clin Microbiol. 1999 May;37(5):1632-3. PMID: 10203544.
  12. Ashley RL. 2001. Sorting out the new HSV type specific antibody tests. Sex Transm Infect. 2001 Aug;77(4):232-7. Review. PMID: 11463920.
  13. Aurelian L, Kokuba H, Smith CC. 1999. Vaccine potential of a herpes simplex virus type 2 mutant deleted in the PK domain of the large subunit of ribonucleotide reductase (ICP10). Vaccine. 1999 Apr 9;17(15-16):1951-63. PMID: 10217594.
  14. Aurelian L, Smith CC. 2000. Herpes simplex virus type 2 growth and latency reactivation by cocultivation are inhibited with antisense oligonucleotides complementary to the translation initiation site of the large subunit of ribonucleotide reductase (RR1). Antisense Nucleic Acid Drug Dev. 2000 Apr;10(2):77-85. PMID: 10805158.
  15. Balbi C, Di Grazia F, Piscitelli V, Martini S, Cardone A, Balbi GC. 1996. [Retrospective study of cervical papillomavirus lesions: early Herpes simplex virus proteins as markers of risk for progression]. Minerva Ginecol. 1996 May;48(5):175-9. Italian. PMID: 8927276.
  16. Barcy S, Corey L. 2001. Herpes simplex inhibits the capacity of lymphoblastoid B cell lines to stimulate CD4+ T cells. J Immunol. 2001 May 15;166(10):6242-9. PMID: 11342647.
  17. Barinskii IF, Bakaev VV, Posevaia TA, Klincheva SA, Nikolaeva NP, Dlinn VV, Shebalina NV. 1994. Selection of primers and their use in the polymerase chain reaction for diagnosing infections caused by herpes simplex virus and cytomegalovirus. Vopr Virusol. 1994 Nov-Dec;39(6):245-7. Russian. PMID: 7716914.
  18. Baron JM, Rubben A, Grussendorf-Conen EI. 1996. Evaluation of a new general primer pair for rapid detection and differentiation of HSV-1, HSV-2, and VZV by polymerase chain reaction. J Med Virol. 1996 Aug;49(4):279-82. PMID: 8877759.
  19. Becker Y. 1992. Computer prediction of antigenic and topogenic domains in HSV-1 and HSV-2 glycoprotein B (gB). Virus Genes. 1992 Apr;6(2):131-41. PMID: 1375407.
  20. Benencia F, Courreges MC, Gamba G, Cavalieri H, Massouh EJ. 2001. Effect of aminoguanidine, a nitric oxide synthase inhibitor, on ocular infection with herpes simplex virus in Balb/c mice. Invest Ophthalmol Vis Sci. 2001 May;42(6):1277-84. PMID: 11328740.
  21. Bergstrom T, Trybala E. 1996. Antigenic differences between HSV-1 and HSV-2 glycoproteins and their importance for type-specific serology. Intervirology. 1996;39(3):176-84. Review. PMID: 9058170.
  22. Bernstein DI, Tepe ER, Mester JC, Arnold RL, Stanberry LR, Higgins T. 1999. Effects of DNA immunization formulated with bupivacaine in murine and guinea pig models of genital herpes simplex virus infection. Vaccine. 1999 Apr 9;17(15-16):1964-9. PMID: 10217595.
  23. Bernstein DI. 2000. Effect of route of vaccination with vaccinia virus expressing HSV-2 glycoprotein D on protection from genital HSV-2 infection. Vaccine. 2000 Jan 31;18(14):1351-8. PMID: 10618532.
  24. Berra A, Dutt JE, Foster CS. 1996. Detection of herpes simplex virus type 1 by an in situ polymerase chain reaction technique. Cornea. 1996 Jan;15(1):55-61. PMID: 8907381.
  25. Biswal N, Patel AG, Max SR. 1988. Regulation of viral and cellular genes in a human neuroblastoma cell line latently infected with herpes simplex virus type 2. Brain Res. 1988 Apr;427(2):95-106. PMID: 2838126.
  26. Black DH, Eberle R. 1997. Detection and differentiation of primate alpha-herpesviruses by PCR. J Vet Diagn Invest. 1997 Jul;9(3):225-31. PMID: 9249159.
  27. Blaho JA, Zong CS, Mortimer KA. 1997. Tyrosine phosphorylation of the herpes simplex virus type 1 regulatory protein 1997. ICP22 and a cellular protein which shares antigenic determinants with ICP22. J Virol. 1997 Dec;71(12):9828-32. PMID: 9371655.
  28. Blaney JE Jr, Nobusawa E, Brehm MA, Bonneau RH, Mylin LM, Fu TM, Kawaoka Y, 1998 Tevethia SS. Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity. J Virol. 1998 Dec;72(12):9567-74. PMID: 9811690.
  29. Bloom DC, Stevens JG. 1994. Neuron-specific restriction of a herpes simplex virus recombinant maps to the UL5 gene. J Virol. 1994 Jun;68(6):3761-72. PMID: 8189514.
  30. Boggess KA, Watts DH, Hobson AC, Ashley RL, Brown ZA, Corey L. 1997. Herpes simplex virus type 2 detection by culture and polymerase chain reaction and relationship to genital symptoms and cervical antibody status during the third trimester of pregnancy. Am J Obstet Gynecol. 1997 Feb;176(2):443-51. PMID: 9065196.
  31. Botma HJ, Dekker H, van Amstel P, Cairo I, van den Berg FM. 1995. Differential in situ hybridization for herpes simplex virus typing in routine skin biopsies. J Virol Methods. 1995 May;53(1):37-45. PMID: 7635926.
  32. Bouquillon C, Dewilde A, Andreoletti L, Lambert V, Chieux V, Gerard Y, Lion 2000. G, Bocket L, Wattre P. Simultaneous detection of 6 human herpesviruses in cerebrospinal fluid and aqueous fluid by a single PCR using stair primers. J Med Virol. 2000 Nov;62(3):349-53. PMID: 11055245.
  33. Bour SP, Aberham C, Perrin C, Strebel K. 1999. Lack of effect of cytoplasmic tail truncations on human immunodeficiency virus type 2 ROD env particle release activity. J Virol. 1999 Jan;73(1):778-82. PMID: 9847387.
  34. Bourne N, Milligan GN, Schleiss MR, Bernstein DI, Stanberry LR. 1996. DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2. Vaccine. 1996 Sep;14(13):1230-4. PMID: 8961510.
  35. Bourne N, Stanberry LR, Bernstein DI, Lew D. 1996. DNA immunization against experimental genital herpes simplex virus infection. Infect Dis. 1996 Apr;173(4):800-7. PMID: 8603957.
  36. Bourne N, Stanberry LR, Connelly BL, Kurawadwala J, Straus SE, Krause PR. 1994. Quantity of latency-associated transcript produced by herpes simplex virus is not predictive of the frequency of experimental recurrent genital herpes. J Infect Dis. 1994 May;169(5):1084-7. PMID: 8169396.
  37. Boursnell ME, Entwisle C, Ali SA, Sivasubramaniam SD, Reeder S, McLean CS, Blakeley DM, Miller J, Hill S, Shields JG, Inglis SC, Rees RC. 1998.1 Disabled infectious single cycle (DISC) herpes simplex virus as a vector for immunotherapy of cancer. Adv Exp Med Biol. 1998;451:379-84. No abstract available. PMID: 10026900.
  38. Boursnell ME, Entwisle C, Blakeley D, Roberts C, Duncan IA, Chisholm SE, Martin GM, Jennings R, Ni Challanain D, Sobek I, Inglis SC, McLean CS. 1997. A genetically inactivated herpes simplex virus type 2 (HSV-2) vaccine provides effective protection against primary and recurrent HSV-2 disease. J Infect Dis. 1997 Jan;175(1):16-25. PMID: 8985191.
  39. Brice SL, Jester JD, Friednash M, Golitz LE, Leahy MA, Stockert SS, Weston WL. 1993. Examination of cutaneous T-cell lymphoma for human herpesviruses by using the polymerase chain reaction. J Cutan Pathol. 1993 Aug;20(4):304-7. PMID: 8227605.
  40. Brown SM, Harland J, MacLean AR, Podlech J, Clements JB. 1994. Cell type and cell state determine differential in vitro growth of non-neurovirulent ICP34.5-negative herpes simplex virus types 1 and 2. J Gen Virol. 1994 Sep;75 ( Pt 9):2367-77. PMID: 8077935.
  41. Brown SM, Harland J. 1987. Three mutants of herpes simplex virus type 2: one lacking the genes US10, US11 and US12 and two in which Rs has been extended by 6 kb to 0.91 map units with loss of Us sequences between 0.94 and the Us/TRs junction. J Gen Virol. 1987 Jan;68 ( Pt 1):1-18. PMID: 3027237.
  42. Burioni R, Williamson RA, Sanna PP, Bloom FE, Burton DR. 1994. Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitro. Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):355-9. PMID: 8278393.
  43. Burke RL, Goldbeck C, Ng P, Stanberry L, Ott G, Van Nest G. 1994. The influence of adjuvant on the therapeutic efficacy of a recombinant genital herpes vaccine. J Infect Dis. 1994 Nov;170(5):1110-9. PMID: 7963702.
  44. Byars NE, Fraser-Smith EB, Pecyk RA, Welch M, Nakano G, Burke RL, Hayward AR, Allison AC. 1994. Vaccinating guinea pigs with recombinant glycoprotein D of herpes simplex virus in an efficacious adjuvant formulation elicits protection against vaginal infection. Vaccine. 1994;12(3):200-9. PMID: 8165851.
  45. Bystricka M, Petrikova M, Zatovicova M, Solarikova L, Kostolansky F, Mucha 1997. V, Russ G. Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection. Acta Virol. 1997 Feb;41(1):5-12. PMID: 9199708.
  46. Campadelli-Fiume G, Stirpe D, Boscaro A, Avitabile E, Foa-Tomasi L, Barker D, Roizman B. 1990. Glycoprotein C-dependent attachment of herpes simplex virus to susceptible cells leading to productive infection. Virology. 1990 Sep;178(1):213-22. PMID: 2167550.
  47. Carmack MA, Yasukawa LL, Chang SY, Tran C, Saldana F, Arvin AM, Prober CG. 1996. T cell recognition and cytokine production elicited by common and type-specific glycoproteins of herpes simplex virus type 1 and type 2. J Infect Dis. 1996 Nov;174(5):899-906. PMID: 8896488.
  48. Cassinotti P, Mietz H, Siegl G. 1996. Suitability and clinical application of a multiplex nested PCR assay for the diagnosis of herpes simplex virus infections. J Med Virol. 1996 Sep;50(1):75-81. PMID: 8890044.
  49. Cassinotti P, Siegl G. 1998. A nested-PCR assay for the simultaneous amplification of HSV-1, HSV-2, and HCMV genomes in patients with presumed herpetic CNS infections. J Virol Methods. 1998 Mar;71(1):105-14. PMID: 9628226.
  50. Chen H, Teng L, Li JN, Park R, Mold DE, Gnabre J, Hwu JR, Tseng WN, Huang RC. 1998. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA. J Med Chem. 1998 Jul 30;41(16):3001-7. PMID: 9685239.
  51. Chiang HY, Cohen GH, Eisenberg RJ. 1994. Identification of functional regions of herpes simplex virus glycoprotein gD by using linker-insertion mutagenesis. J Virol. 1994 Apr;68(4):2529-43. PMID: 7511173.
  52. Chiba A, Suzutani T, Saijo M, Koyano S, Azuma M. 1998. Analysis of nucleotide sequence variations in herpes simplex virus types 1 and 2, and varicella-zoster virus. Acta Virol. 1998 Dec;42(6):401-7. PMID: 10358747.
  53. Cocchi F, Lopez M, Menotti L, Aoubala M, Dubreuil P, Campadelli-Fiume G. 1998. The V domain of herpesvirus Ig-like receptor (HIgR) contains a major functional region in herpes simplex virus-1 entry into cells and interacts physically with the viral glycoprotein D. Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15700-5. PMID: 9861033.
  54. Cocchi F, Menotti L, Mirandola P, Lopez M, Campadelli-Fiume G. 1998. The ectodomain of a novel member of the immunoglobulin subfamily related to the poliovirus receptor has the attributes of a bona fide receptor for herpes simplex virus types 1 and 2 in human cells. J Virol. 1998 Dec;72(12):9992-10002. PMID: 9811737.
  55. Cockerham GC, Bijwaard K, Sheng ZM, Hidayat AA, Font RL, McLean IW. 2000. Primary graft failure : a clinicopathologic and molecular analysis. Ophthalmology. 2000 Nov;107(11):2083-90;discussion 2090-1. PMID: 11054337.
  56. Cockrell AS, Muggeridge MI. 1998. Herpes simplex virus 2 UL45 is a type II membrane protein. J Virol. 1998 May;72(5):4430-3. PMID: 9557736.
  57. Coffin RS, Thomas SK, Thomas DP, Latchman DS. 1998. The herpes simplex virus 2 kb latency associated transcript (LAT) leader sequence allows efficient expression of downstream proteins which is enhanced in neuronal cells: possible function of LAT ORFs. J Gen Virol. 1998 Dec;79 ( Pt 12):3019-26. No abstract available. PMID: 9880017.
  58. Cohen BA, Rowley AH, Long CM. 1994. Herpes simplex type 2 in a patient with Mollaret's meningitis: demonstration by polymerase chain reaction. Ann Neurol. 1994 Jan;35(1):112-6. PMID: 8285581.
  59. Conley AJ, Knipe DM, Jones PC, Roizman B. 1981. Molecular genetics of herpes simplex virus. VII. Characterization of a temperature-sensitive mutant produced by in vitro mutagenesis and defective in DNA synthesis and accumulation of gamma polypeptides. J Virol. 1981 Jan;37(1):191-206. PMID: 6260973.
  60. Contreras A, Zadeh HH, Nowzari H, Slots J. 1999. Herpesvirus infection of inflammatory cells in human periodontitis. Oral Microbiol Immunol. 1999 Aug;14(4):206-12. PMID: 10551163.
  61. Corey L, Hobson A, Schacker T. 1996. Lack of detection of HSV DNA in PBMCs and lymph nodes of HIV-infected persons. J Med Virol. 1996 Jan;48(1):47. No abstract available. PMID: 8825709.
  62. Corey L, Langenberg AG, Ashley R, Sekulovich RE, Izu AE, Douglas JM Jr, Handsfield HH, Warren T, Marr L, Tyring S, DiCarlo R, Adimora AA, Leone P, Dekker CL, Burke RL, Leong WP, Straus SE. 1999. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. JAMA. 1999 Jul 28;282(4):331-40. PMID: 10432030.
  63. Costa S, Smith CC, Taylor S, Aurelian L, Orlandi C. 1986. Intracellular localization and serological identification of a HSV-2 protein in cervical cancer. Eur J Gynaecol Oncol. 1986;7(1):1-12. PMID: 3009194.
  64. Cress A, Triezenberg SJ. 1991. Nucleotide and deduced amino acid sequences of the gene encoding virion protein 16 of herpes simplex virus type 2. Gene. 1991 Jul 22;103(2):235-8. PMID: 1653757.
  65. Cunningham C, Davison AJ, Dolan A, Frame MC, McGeoch DJ, Meredith DM, Moss HW, Orr AC. 1992. The UL13 virion protein of herpes simplex virus type 1 is phosphorylated by a novel virus-induced protein kinase. J Gen Virol. 1992 Feb;73 ( Pt 2):303-11. PMID: 1311359.
  66. Cunningham ET Jr, Short GA, Irvine AR, Duker JS, Margolis TP. 1996. Acquired immunodeficiency syndrome--associated herpes simplex virus retinitis. Clinical description and use of a polymerase chain reaction--based assay as a diagnostic tool. Arch Ophthalmol. 1996 Jul;114(7):834-40. PMID: 8660167.
  67. Da Costa X, Kramer MF, Zhu J, Brockman MA, Knipe DM. 2000. Construction, phenotypic analysis, and immunogenicity of a UL5/UL29 double deletion mutant of herpes simplex virus 2. J Virol. 2000 Sep;74(17):7963-71. PMID: 10933704.
  68. Da Costa XJ, Bourne N, Stanberry LR, Knipe DM. 1997. Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital disease. Virology. 1997 May 26;232(1):1-12. PMID: 9185583.
  69. Da Rosa-Santos OL, Goncalves Da Silva A, Pereira AC Jr. 1996. Herpes simplex virus type 2 in Brazil: seroepidemiologic survey. Int J Dermatol. 1996 Nov;35(11):794-6. PMID: 8915732.
  70. Daikoku T, Kurachi R, Tsurumi T, Nishiyama Y. 1994. Identification of a target protein of US3 protein kinase of herpes simplex virus type 2. J Gen Virol. 1994 Aug;75 ( Pt 8):2065-8. PMID: 8046410.
  71. Daikoku T, Yamashita Y, Tsurumi T, Maeno K, Nishiyama Y. 1993. Purification and biochemical characterization of the protein kinase encoded by the US3 gene of herpes simplex virus type 2. Virology. 1993 Dec;197(2):685-94. PMID: 8249291.
  72. Damhof RA, Feijlbrief M, Welling-Wester S, Welling GW. 1994. Purification of the integral membrane glycoproteins D of herpes simplex virus types 1 and 2, produced in the recombinant baculovirus expression system, by ion-exchange high-performance liquid chromatography. J Chromatogr A. 1994 Jul 29;676(1):43-9. PMID: 7921180.
  73. Dan K, Miyashita K, Seto Y, Yamase T. 1998. Quantitation of herpes simplex viral DNA in Vero cells for evaluation of an antiviral agent using the polymerase chain reaction. J Virol Methods. 1998 Dec;76(1-2):73-9. PMID: 9923741.
  74. Danaher RJ, Jacob RJ, Miller CS. 2000. Herpesvirus quiescence in neuronal cells: antiviral conditions not required to establish and maintain HSV-2 quiescence. J Neurovirol. 2000 Aug;6(4):296-302. PMID: 10951553.
  75. Davidson I, Tanaka A, Nonoyama M. 1995. Common antigenic epitopes are present on heat-labile oligomers of MDV glycoprotein B and on HSV glycoprotein B. Virus Res. 1995 Mar;35(3):233-45. PMID: 7540344.
  76. de Boer JH, Verhagen C, Bruinenberg M, Rothova A, de Jong PT, Baarsma GS, Van der Lelij A, Ooyman FM, Bollemeijer JG, Derhaag PJ, Kijlstra A. 1996. Serologic and polymerase chain reaction analysis of intraocular fluids in the diagnosis of infectious uveitis. Am J Ophthalmol. 1996 Jun;121(6):650-8. PMID: 8644808.
  77. De Logu A, Williamson RA, Rozenshteyn R, Ramiro-Ibanez F, Simpson CD, 1998. Burton DR, Sanna PP. Characterization of a type-common human recombinant monoclonal antibody to herpes simplex virus with high therapeutic potential. J Clin Microbiol. 1998 Nov;36(11):3198-204. PMID: 9774565.
  78. Dean HJ, Warner MS, Terhune SS, Johnson RM, Spear PG. 1995. Viral determinants of the variable sensitivity of herpes simplex virus strains to gD-mediated interference. J Virol. 1995 Aug;69(8):5171-6. PMID: 7609090.
  79. Degreve B, Johansson M, De Clercq E, Karlsson A, Balzarini J. 1998. Differential intracellular compartmentalization of herpetic thymidine kinases (TKs) in TK gene-transfected tumor cells: molecular characterization of the nuclear localization signal of herpes simplex virus type 1 TK. J Virol. 1998 Dec;72(12):9535-43. PMID: 9811686.
  80. Dennett C, Cleator GM, Klapper PE. 1997. HSV-1 and HSV-2 in herpes simplex encephalitis: a study of sixty-four cases in the United Kingdom. J Med Virol. 1997 Sep;53(1):1-3. PMID: 9298724.
  81. Dennison DK, Meredith GM, Shillitoe EJ, Caffesse RG. 1995. The antiviral spectrum of Listerine antiseptic. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 Apr;79(4):442-8. PMID: 7614202.
  82. Detilleux M, Tournaire M, Christoforov B. 1996. Recurring episodes of meningitis (Mollaret's meningitis) with one showing an association with herpes simplex virus type 2. J Infect. 1996 May;32(3):247-8. PMID: 8793718.
  83. DiPaolo JA, Woodworth CD, Coutlee F, Zimonic DB, Bryant J, Kessous A. 1998 Relationship of stable integration of herpes simplex virus-2 Bg/II N subfragment Xho2 to malignant transformation of human papillomavirus-immortalized cervical keratinocytes. Int J Cancer. 1998 Jun 10;76(6):865-71. PMID: 9626354.
  84. Dixon RA, Sabourin DJ, Schaffer PA. 1983. Genetic analysis of temperature-sensitive mutants which define the genes for the major herpes simplex virus type 2 DNA-binding protein and a new late function. J Virol. 1983 Jan;45(1):343-53. PMID: 6296441.
  85. do Nascimento MC, Sumita LM, de Souza VA, Pannuti CS. 1998. Detection and direct typing of herpes simplex virus in perianal ulcers of patients with AIDS by PCR. J Clin Microbiol. 1998 Mar;36(3):848-9. PMID: 9508331.
  86. Doherty DG, Penzotti JE, Koelle DM, Kwok WW, Lybrand TP, Masewicz S, Nepom GT. 1998. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR. J Immunol. 1998 Oct 1;161(7):3527-35. PMID: 9759873.
  87. Dolan A, Jamieson FE, Cunningham C, Barnett BC, McGeoch DJ. 1998. The genome sequence of herpes simplex virus type 2. J Virol. 1998 Mar;72(3):2010-21. PMID: 9499055.
  88. Dolter KE, Goins WF, Levine M, Glorioso JC. 1992. Genetic analysis of type-specific antigenic determinants of herpes simplex virus glycoprotein C. J Virol. 1992 Aug;66(8):4864-73. PMID: 1378512.
  89. Domingues RB, Lakeman FD, Pannuti CS, Fink MC, Tsanaclis AM. 1997. Advantage of polymerase chain reaction in the diagnosis of herpes simplex encephalitis: presentation of 5 atypical cases. Scand J Infect Dis. 1997;29(3):229-31. PMID: 9255880.
  90. Dupuis M, McDonald DM, Ott G. 1999. Distribution of adjuvant MF59 and antigen gD2 after intramuscular injection in mice. Vaccine. 1999 Oct 14;18(5-6):434-9. PMID: 10519932.
  91. Dupuis M, Murphy TJ, Higgins D, Ugozzoli M, van Nest G, Ott G, McDonald DM. 1998. Dendritic cells internalize vaccine adjuvant after intramuscular injection. Cell Immunol. 1998 May 25;186(1):18-27. PMID: 9637761.
  92. Dyer AP, Banfield BW, Martindale D, Spannier DM, Tufaro F. 1997. Dextran sulfate can act as an artificial receptor to mediate a type-specific herpes simplex virus infection via glycoprotein B. J Virol. 1997 Jan;71(1):191-8. PMID: 8985338.
  93. Eberle R, Black D, Hilliard JK. 1989. Relatedness of glycoproteins expressed on the surface of simian herpes-virus virions and infected cells to specific HSV glycoproteins. Arch Virol. 1989;109(3-4):233-52. PMID: 2482016.
  94. Eberle R, Mou SW, Zaia JA. 1984. Polypeptide specificity of the early antibody response following primary and recurrent genital herpes simplex virus type 2 infections. J Gen Virol. 1984 Oct;65 ( Pt 10):1839-43. PMID: 6387042.
  95. Eis-Hubinger AM, Daumer M, Matz B, Schneweis KE. 1999. Evaluation of three glycoprotein G2-based enzyme immunoassays for detection of antibodies to herpes simplex virus type 2 in human sera. J Clin Microbiol. 1999 May;37(5):1242-6. PMID: 10203464.
  96. Ellie E, Rozenberg F, Dousset V, Beylot-Barry M. 1994. Herpes simplex virus type 2 ascending myeloradiculitis: MRI findings and rapid diagnosis by the polymerase chain method. J Neurol Neurosurg Psychiatry. 1994 Jul;57(7):869-70. No abstract available. PMID: 8021686.
  97. Evans LA, Sheppard M, May JT. 1985. Analysis of the HSV-2 early AG-4 antigen. Arch Virol. 1985;85(1-2):13-23. PMID: 2990385.
  98. Everly DN Jr, Read GS. 1999. Site-directed mutagenesis of the virion host shutoff gene (UL41) of herpes simplex virus (HSV): analysis of functional differences between HSV type 1 (HSV-1) and HSV-2 alleles. J Virol. 1999 Nov;73(11):9117-29. PMID: 10516018.
  99. Fang XF, Song B, Tu YY, Tong JZ, Faul JL, Bai H. 1999. Rapid detection of glycoprotein G gene for the diagnosis and typing of herpes simplex virus infection in genital herpes. Sex Transm Infect. 1999 Dec;75(6):396-7. PMID: 10754943.
  100. Fennewald SM, Mustain S, Ojwang J, Rando RF. 1995. Inhibition of herpes simplex virus in culture by oligonucleotides composed entirely of deoxyguanosine and thymidine. Antiviral Res. 1995 Jan;26(1):37-54. PMID: 7741520.
  101. Fenwick ML, Everett RD. 1990. Transfer of UL41, the gene controlling virion-associated host cell shutoff, between different strains of herpes simplex virus. J Gen Virol. 1990 Feb;71 ( Pt 2):411-8. PMID: 2155295.
  102. Ferrante P, Mancuso R, Pagani E, Guerini FR, Calvo MG, Saresella M, Speciale 2000. L, Caputo D. Molecular evidences for a role of HSV-1 in multiple sclerosis clinical acute attack. J Neurovirol. 2000 May;6 Suppl 2:S109-14. PMID: 10871797.
  103. Fleck M, Mountz JD, Hsu HC, Wu J, Edwards CK 3rd, Kern ER.1999. Herpes simplex virus type 2 infection induced apoptosis in peritoneal macrophages independent of Fas and tumor necrosis factor-receptor signaling. Viral Immunol. 1999;12(3):263-75. PMID: 10532654.
  104. Fleck M, Podlech J, Weise K, Falke D. 1994. A vaccinia virus--herpes simplex virus (HSV) glycoprotein B1 recombinant or an HSV vaccine overcome the HSV type 2 induced humoral immunosuppression and protect against vaginal challenge in BALB/c mice. Med Microbiol Immunol (Berl). 1994 May;183(2):87-94. PMID: 7935163.
  105. Flo J, Beatriz Perez A, Tisminetzky S, Baralle F. 2000. Superiority of intramuscular route and full length glycoprotein D for DNA vaccination against herpes simplex 2. Enhancement of protection by the co-delivery of the GM-CSF gene. Vaccine. 2000 Aug 1;18(28):3242-53. PMID: 10869769.
  106. Flo J, Tisminetzky S, Baralle F. 2000. Modulation of the immune response to DNA vaccine by co-delivery of costimulatory molecules. Immunology. 2000 Jun;100(2):259-67. PMID: 10886404.
  107. Flo J, Tisminetzky S, Baralle F. 2001. Oral transgene vaccination mediated by attenuated Salmonellae is an effective method to prevent Herpes simplex virus-2 induced disease in mice. Vaccine. 2001 Feb 8;19(13-14):1772-82. PMID: 11166903.
  108. Friedman HM. 2000. Immunologic strategies for herpes vaccination. JAMA. 2000 Feb 9;283(6):746; discussion 746-7. No abstract available. PMID: 10683051.
  109. Fujiwara M, Ashida N, Okamoto M, Mizuta T, Ide T, Hanasaki Y, Katsuura K, Sawada H, Shigeta S, Konno K, Yokota T, Baba M. 1998. RD6-2198, a novel betain-type fluoroalkylated oligomer, inhibits the replications of human immunodeficiency virus type 1 and other enveloped viruses. Antiviral Res. 1998 May;38(2):141-9. PMID: 9707376.
  110. Gallichan WS, Johnson DC, Graham FL, Rosenthal KL. 1995. Mucosal immunization with a recombinant adenovirus vector induces local and systemic immunity and protection from herpes simplex virus. Adv Exp Med Biol. 1995;371B:1581-5. No abstract available. PMID: 7502860.
  111. Gallichan WS, Rosenthal KL. 1996 Effects of the estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex virus type 2 infection in the genital tract. Virology. 1996 Oct 15;224(2):487-97. PMID: 8874509.
  112. Gallichan WS, Rosenthal KL. 1996. Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization. J Exp Med. 1996 Nov 1;184(5):1879-90. PMID: 8920875.
  113. Gallichan WS, Woolstencroft RN, Guarasci T, McCluskie MJ, Davis HL, 2001. Rosenthal KL. Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract. J Immunol. 2001 Mar 1;166(5):3451-7. PMID: 11207303.
  114. Galloway DA, McDougall JK. 1990. Alterations in the cellular phenotype induced by herpes simplex viruses. J Med Virol. 1990 May;31(1):36-42. Review. PMID: 2165516.
  115. Ganatra JB, Chandler D, Santos C, Kuppermann B, Margolis TP. 2000. Viral causes of the acute retinal necrosis syndrome. Am J Ophthalmol. 2000 Feb;129(2):166-72. PMID: 10682968.
  116. Garcia-Corbeira P, Hogrefe W, Aguilar L, Garcia-de-Lomas J, Gil A, Bayas JM, 1999. Vilella A, Dal-Re R. Whole cell lysate enzyme immunoassays vs. recombinant glycoprotein G2-based immunoassays for HSV-2 seroprevalence studies. J Med Virol. 1999 Dec;59(4):502-6. PMID: 10534733.
  117. Gatfield J, Lammert E, Nickolaus P, Munz C, Rothenfusser S, Fisch P, 1998. Stevanovic S, Schild H, Rammensee HG, Arnold D. Cell lines transfected with the TAP inhibitor ICP47 allow testing peptide binding to a variety of HLA class I molecules. Int Immunol. 1998 Nov;10(11):1665-72. PMID: 9846695.
  118. Gazzaniga P, Vercillo R, Gradilone A, Silvestri I, Gandini O, Napolitano M, Giuliani L, Fioravanti A, Gallucci M, Agliano AM. 1998. Prevalence of papillomavirus, Epstein-Barr virus, cytomegalovirus, and herpes simplex virus type 2 in urinary bladder cancer. J Med Virol. 1998 Aug;55(4):262-7. PMID: 9661833.
  119. Gebhard JR, Zhu J, Cao X, Minnick J, Araneo BA. 2000. DNA immunization utilizing a herpes simplex virus type 2 myogenic DNA vaccine protects mice from mortality and prevents genital herpes. Vaccine. 2000 Mar 6;18(17):1837-46. PMID: 10699332.
  120. Geraghty RJ, Fridberg A, Krummenacher C, Cohen GH, Eisenberg RJ, Spear PG. 2001. Use of chimeric nectin-1(HveC)-related receptors to demonstrate that ability to bind alphaherpesvirus gD is not necessarily sufficient for viral entry. Virology. 2001 Jul 5;285(2):366-75. PMID: 11437670.
  121. Geraghty RJ, Krummenacher C, Cohen GH, Eisenberg RJ, Spear PG. 1998. Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science. 1998 Jun 5;280(5369):1618-20. PMID: 9616127.
  122. Gerber SI, Belval BJ, Herold BC. 1995. Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism. Virology. 1995 Dec 1;214(1):29-39. PMID: 8525631.
  123. Gibson MG, Spear PG. 1983. Insertion mutants of herpes simplex virus have a duplication of the glycoprotein D gene and express two different forms of glycoprotein D. J Virol. 1983 Nov;48(2):396-404. PMID: 6312097.
  124. Gilman SC, Docherty JJ, Clarke A, Rawls WE. 1980. Reaction patterns of herpes simplex virus type 1 and type 2 proteins with sera of patients with uterine cervical carcinoma and matched controls. Cancer Res. 1980 Dec;40(12):4640-7. PMID: 6254649.
  125. Gilman SC, Docherty JJ, Rawls WE. 1981. Antibody responses in humans to individual proteins of herpes simplex viruses. Infect Immun. 1981 Dec;34(3):880-7. PMID: 6277791.
  126. Goade DE, Bell R, Yamada T, Mertz GJ, Jenison S. 1996. Locations of herpes simplex virus type 2 glycoprotein B epitopes recognized by human serum immunoglobulin G antibodies. J Virol. 1996 May;70(5):2950-6. PMID: 8627770.
  127. Gomez E, Melon S, de Ona M, Alvarez R, Laures A, Alvarez-Grande J. 1999. Disseminated herpes simplex virus infection in a renal transplant patient as possible cause of repeated urinary extravasations. Nephron. 1999;82(1):59-64. PMID: 10224485.
  128. Gonzalez-Villasenor LI. 1999. A duplex PCR assay for detection and genotyping of Herpes simplex virus in cerebrospinal fluid. Mol Cell Probes. 1999 Aug;13(4):309-14. PMID: 10441204.
  129. Goshima F, Daikoku T, Yamada H, Oshima S, Tsurumi T, Nishiyama Y. 1998. Subcellular localization of the US3 protein kinase of herpes simplex virus type 2. Arch Virol. 1998;143(3):613-22. PMID: 9572561.
  130. Goshima F, Watanabe D, Takakuwa H, Wada K, Daikoku T, Yamada M, Nishiyama Y. 2000. Herpes simplex virus UL17 protein is associated with B capsids and colocalizes with ICP35 and VP5 in infected cells. Arch Virol. 2000;145(2):417-26. PMID: 10752563.
  131. Grabowska A, Jameson C, Laing P, Jeansson S, Sjogren-Jansson E, Taylor J, 1999. Cunningham A, Irving WL. Identification of type-specific domains within glycoprotein G of herpes simplex virus type 2 (HSV-2) recognized by the majority of patients infected with HSV-2, but not by those infected with HSV-1. J Gen Virol. 1999 Jul;80 ( Pt 7):1789-98. PMID: 10423148.
  132. Grabowska AM, Jennings R, Laing P, Darsley M, Jameson CL, Swift L, Irving 2000. WL. Immunisation with phage displaying peptides representing single epitopes of the glycoprotein G can give rise to partial protective immunity to HSV-2. Virology. 2000 Mar 30;269(1):47-53. PMID: 10725197.
  133. Gressens P, Martin JR. 1994. HSV-2 DNA persistence in astrocytes of the trigeminal root entry zone: double labeling by in situ PCR and immunohistochemistry. J Neuropathol Exp Neurol. 1994 Mar;53(2):127-35. PMID: 8120536.
  134. Groen J, Hersmus B, Niesters HG, Roest W, van Dijk G, van der Meijden W, Osterhaus AD. 1999. Evaluation of a fully automated glycoprotein G-2 based assay for the detection of HSV-2 specific IgG antibodies in serum and plasma. J Clin Virol. 1999 May;12(3):193-200. PMID: 10382816.
  135. Guibinga GH, Coutlee F, Kessous A, Hankins C, Lapointe N, Richer G, Tousignant J. 1996. Detection of a transforming fragment of herpes simplex virus type 2 in clinical specimens by PCR. The Canadian Women's HIV Study Group. J Clin Microbiol. 1996 Jul;34(7):1654-9. PMID: 8784564.
  136. Hamouda T, McPhee R, Hsia SC, Read GS, Holland TC, King SR. 1997. Inhibition of human immunodeficiency virus replication by the herpes simplex virus virion host shutoff protein. J Virol. 1997 Jul;71(7):5521-7. PMID: 9188626.
  137. Hanson N, Henderson G, Jones C. 1994. The herpes simplex virus type 2 gene which encodes the large subunit of ribonucleotide reductase has unusual regulatory properties. Virus Res. 1994 Dec;34(3):265-80. PMID: 7856314.
  138. Hara Y, Kimoto T, Okuno Y, Minekawa Y. 1997. Effect of herpes simplex virus on the DNA of human papillomavirus 18. J Med Virol. 1997 Sep;53(1):4-12. PMID: 9298725.
  139. Harland JE, Bdour S, Brown SM, MacLean AR. 1996. The herpes simplex virus type 2 strain HG52 RL1 gene contains a 154 bp intron as predicted from sequence analysis. J Gen Virol. 1996 Mar;77 ( Pt 3):481-4. PMID: 8601785.
  140. Harle P, Noisakran S, Carr DJ. 2001. The application of a plasmid DNA encoding IFN-alpha 1 postinfection enhances cumulative survival of herpes simplex virus type 2 vaginally infected mice. J Immunol. 2001 Feb 1;166(3):1803-12. PMID: 11160227.
  141. Harrison CJ, Miller RL, Bernstein DI. 2001. Reduction of recurrent HSV disease using imiquimod alone or combined with a glycoprotein vaccine. Vaccine. 2001 Feb 8;19(13-14):1820-6. PMID: 11166907.
  142. Hashido M, Lee FK, Inouye S, Kawana T. 1997. Detection of herpes simplex virus type-specific antibodies by an enzyme-linked immunosorbent assay based on glycoprotein G. J Med Virol. 1997 Dec;53(4):319-23. PMID: 9407378.
  143. Hashido M, Lee FK, Nahmias AJ, Kawana T. 1997. Prevalence of herpes simplex virus type 1- and 2- specific antibodies among the acute, recurrent, and provoked types of female genital herpes. Microbiol Immunol. 1997;41(10):823-7. PMID: 9403510.
  144. Hata S, Koyama AH, Shiota H, Adachi A, Goshima F, Nishiyama Y. 1999. Antiapoptotic activity of herpes simplex virus type 2: the role of US3 protein kinase gene. Microbes Infect. 1999 Jul;1(8):601-7. PMID: 10611736.
  145. Hayward GS, Ambinder R, Ciufo D, Hayward SD, LaFemina RL. 1984. Structural organization of human herpesvirus DNA molecules. J Invest Dermatol. 1984 Jul;83(1 Suppl):29s-41s. Review. PMID: 6330219.
  146. Heineman TC, Connelly BL, Bourne N, Stanberry LR, Cohen J. 1995. Immunization with recombinant varicella-zoster virus expressing herpes simplex virus type 2 glycoprotein D reduces the severity of genital herpes in guinea pigs. J Virol. 1995 Dec;69(12):8109-13. PMID: 7494331.
  147. Hill AB, Barnett BC, McMichael AJ, McGeoch DJ. 1994. HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus types 1 and 2. J Immunol. 1994 Mar 15;152(6):2736-41. PMID: 8144880.
  148. Hilliard JK, Black D, Eberle R. 1989. Simian alphaherpesviruses and their relation to the human herpes simplex viruses. Arch Virol. 1989;109(1-2):83-102. PMID: 2558632.
  149. Ho DW, Field PR, Irving WL, Packham DR, Cunningham AL. 1993. Detection of immunoglobulin M antibodies to glycoprotein G-2 by western blot (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections. J Clin Microbiol. 1993 Dec;31(12):3157-64. PMID: 7508453.
  150. Ho RJ, Burke RL, Merigan TC. 1994. Disposition of antigen-presenting liposomes in vivo: effect on presentation of herpes simplex virus antigen rgD. Vaccine. 1994;12(3):235-42. PMID: 8165856.
  151. Hobson A, Wald A, Wright N, Corey L. 1997. Evaluation of a quantitative competitive PCR assay for measuring herpes simplex virus DNA content in genital tract secretions. J Clin Microbiol. 1997 Mar;35(3):548-52. PMID: 9041386.
  152. Hoog SS, Smith WW, Qiu X, Janson CA, Hellmig B, McQueney MS, O'Donnell K, 1997. O'Shannessy D, DiLella AG, Debouck C, Abdel-Meguid SS. Active site cavity of herpesvirus proteases revealed by the crystal structure of herpes simplex virus protease/inhibitor complex. Biochemistry. 1997 Nov 18;36(46):14023-9. PMID: 9369473.
  153. Hui EK, Lo SJ. 1998. Does the latency associated transcript (LAT) of herpes simplex virus (HSV) function as a ribozyme during viral reactivation? Virus Genes. 1998;16(2):147-8. PMID: 9608658.
  154. Ishizaka ST, Piacente P, Silva J, Mishkin EM. 1995. IgG subtype is correlated with efficiency of passive protection and effector function of anti-herpes simplex virus glycoprotein D monoclonal antibodies. J Infect Dis. 1995 Oct;172(4):1108-11. PMID: 7561190.
  155. Itoh N, Matsumura N, Ogi A, Nishide T, Imai Y, Kanai H, Ohno S. 2000. High prevalence of herpes simplex virus type 2 in acute retinal necrosis syndrome associated with herpes simplex virus in Japan. Am J Ophthalmol. 2000 Mar;129(3):404-5. PMID: 10704570.
  156. Jacobs JJ, Folkers E, Vreeswijk J. 1999. Detection of varicella-zoster virus and herpes simplex virus by the polymerase chain reaction with degenerate primers. J Virol Methods. 1999 Dec;83(1-2):155-67. PMID: 10598093.
  157. Jensenius M, Myrvang B, Storvold G, Bucher A, Hellum KB, Bruu AL. 1998. Herpes simplex virus type 2 DNA detected in cerebrospinal fluid of 9 patients with Mollaret's meningitis. Acta Neurol Scand. 1998 Sep;98(3):209-12. PMID: 9786620.
  158. Jerome KR, Fox R, Chen Z, Sears AE, Lee Hy, Corey L. 1999. Herpes simplex virus inhibits apoptosis through the action of two genes, Us5 and Us3. J Virol. 1999 Nov;73(11):8950-7. PMID: 10516000.
  159. Jiang YM, Yamada H, Goshima F, Daikoku T, Oshima S, Wada K, Nishiyama Y. 1998. Characterization of the herpes simplex virus type 2 (HSV-2) US2 gene product and a US2-deficient HSV-2 mutant. J Gen Virol. 1998 Nov;79 ( Pt 11):2777-84. PMID: 9820154.
  160. Jones AC, Gulley ML, Freedman PD. 2000. Necrotizing ulcerative stomatitis in human immunodeficiency virus-seropositive individuals: a review of the histopathologic, immunohistochemical, and virologic characteristics of 18 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000 Mar;89(3):323-32. PMID: 10710458.
  161. Jones CA, Taylor TJ, Knipe DM. 2000. Biological properties of herpes simplex virus 2 replication-defective mutant strains in a murine nasal infection model. Virology. 2000 Dec 5;278(1):137-50. PMID: 11112490.
  162. Jugovic P, Hill AM, Tomazin R, Ploegh H, Johnson DC. 1998. Inhibition of major histocompatibility complex class I antigen presentation in pig and primate cells by herpes simplex virus type 1 and 2 ICP47. J Virol. 1998 Jun;72(6):5076-84. PMID: 9573278.
  163. Kakkanas A, Papadogeorgaki H, Manservigi R, Miriagou V, Georgopoulou U, 1996. Mavromara P. Escherichia coli expressed herpes simplex virus gG1 and gG2 proteins in ELISA and immunoblotting assays. Intervirology. 1995;38(6):346-51. PMID: 8880385.
  164. Karlsson R, Jonsson M, Edlund K, Evander M, Gustavsson A, Boden E, Rylander E, Wadell G. 1995. Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population-based study. Sex Transm Dis. 1995 Mar-Apr;22(2):119-27. PMID: 7624813.
  165. Kato K, Daikoku T, Goshima F, Kume H, Yamaki K, Nishiyama Y. 2000. Synthesis, subcellular localization and VP16 interaction of the herpes simplex virus type 2 UL46 gene product. Arch Virol. 2000;145(10):2149-62. PMID: 11087097.
  166. Kessler HH, Muhlbauer G, Rinner B, Stelzl E, Berger A, Dorr HW, Santner B, 2000. Marth E, Rabenau H. Detection of Herpes simplex virus DNA by real-time PCR. J Clin Microbiol. 2000 Jul;38(7):2638-42. PMID: 10878056.
  167. Keywan K, Katz E. 2000. The antiviral activity exerted by vaccinia virus on the growth of herpes simplex virus in BS-C-1 cells. Antiviral Res. 2000 May;46(2):145-55. PMID: 10854666.
  168. Kinjo T, Tsuhako K, Sirirungsi W, Sunagawa K, Nakazato I, Iwamasa T. 1997. Experimental myelitis caused by herpes simplex virus type 2 in C57BL/6N and BALB/cN mice. Int J Exp Pathol. 1997 Dec;78(6):401-9. PMID: 9516872.
  169. Kobayashi K, Ohgitani E, Tanaka Y, Kita M, Imanishi J. 1994. Herpes simplex virus-induced expression of 70 kDa heat shock protein (HSP70) requires early protein synthesis but not viral DNA replication. Microbiol Immunol. 1994;38(4):321-5. PMID: 7935054.
  170. Kocsis E, Cerritelli ME, Trus BL, Cheng N, Steven AC. 1995. Improved methods for determination of rotational symmetries in macromolecules. Ultramicroscopy. 1995 Sep;60(2):219-28. PMID: 7502382.
  171. Koelle DM, Chen HB, Gavin MA, Wald A, Kwok WW, Corey L. 2001. CD8 CTL from genital herpes simplex lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells. J Immunol. 2001 Mar 15;166(6):4049-58. PMID: 11238653.
  172. Koelle DM, Corey L, Burke RL, Eisenberg RJ, Cohen GH, Pichyangkura R, Triezenberg SJ. 1994. Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions. J Virol. 1994 May;68(5):2803-10. PMID: 7512152.
  173. Koelle DM, Frank JM, Johnson ML, Kwok WW. 1998. Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions. J Virol. 1998 Sep;72(9):7476-83. PMID: 9696844.
  174. Koelle DM, Johnson ML, Ekstrom AN, Byers P, Kwok WW. 1997. Preferential presentation of herpes simplex virus T-cell antigen by HLA DQA1*0501/DQB1*0201 in comparison to HLA DQA1*0201/DQB1*0201. Hum Immunol. 1997 Apr 1;53(2):195-205. PMID: 9129979.
  175. Koelle DM, Schomogyi M, McClurkan C, Reymond SN, Chen HB. 2000. CD4 T-cell responses to herpes simplex virus type 2 major capsid protein VP5: comparison with responses to tegument and envelope glycoproteins. J Virol. 2000 Dec;74(23):11422-5. PMID: 11070045.
  176. Kohl S, Charlebois ED, Sigouroudinia M, Goldbeck C, Hartog K, Sekulovich RE, 2000. Langenberg AG, Burke RL. Limited antibody-dependent cellular cytotoxicity antibody response induced by a herpes simplex virus type 2 subunit vaccine. J Infect Dis. 2000 Jan;181(1):335-9. PMID: 10608784.
  177. Kotronias D, Kapranos N. 1998. Detection of herpes simplex virus DNA in human spermatozoa by in situ hybridization technique. In Vivo. 1998 Jul-Aug;12(4):391-4. PMID: 9706490.
  178. Kotronias D, Kapranos N. 1999. Detection of herpes simplex virus DNA in maternal breast milk by in situ hybridization with tyramide signal amplification. In Vivo. 1999 Nov-Dec;13(6):463-6. PMID: 10757038.
  179. Kozovska M, Zang YC, Aebischer I, Lnu S, Rivera VM, Crowe PD, Boehme SA, Zhang JZ. 1998. T cell recognition motifs of an immunodominant peptide of myelin basic protein in patients with multiple sclerosis: structural requirements and clinical implications. Eur J Immunol. 1998 Jun;28(6):1894-901. PMID: 9645371.
  180. Krause PR, Stanberry LR, Bourne N, Connelly B, Kurawadwala JF, Patel A, Straus SE. 1995. Expression of the herpes simplex virus type 2 latency-associated transcript enhances spontaneous reactivation of genital herpes in latently infected guinea pigs. J Exp Med. 1995 Jan 1;181(1):297-306. PMID: 7807009.
  181. Kudelova M, Muranyiova M, Kudela O, Rajcani J, Lehtinen M, Stankovic J, 1995. Arvaja M, Balint O. Detection of herpes simplex virus DNA by polymerase chain reaction in the cerebrospinal fluid of patients with viral meningoencephalitis using primers for the glycoprotein D gene. Acta Virol. 1995 Feb;39(1):11-7. PMID: 7572464.
  182. Kurachi R, Daikoku T, Tsurumi T, Maeno K, Nishiyama Y, Kurata T. 1993. The pathogenicity of a US3 protein kinase-deficient mutant of herpes simplex virus type 2 in mice. Arch Virol. 1993;133(3-4):259-73. PMID: 8257288.
  183. Kwok WW, Liu AW, Novak EJ, Gebe JA, Ettinger RA, Nepom GT, Reymond SN, 2000. Koelle DM. HLA-DQ tetramers identify epitope-specific T cells in peripheral blood of herpes simplex virus type 2-infected individuals: direct detection of immunodominant antigen-responsive cells. J Immunol. 2000 Apr 15;164(8):4244-9. PMID: 10754321.
  184. Kwong AD, Kruper JA, Frenkel N. 1988. Herpes simplex virus virion host shutoff function. J Virol. 1988 Mar;62(3):912-21. PMID: 2828686.
  185. Larsson C, Bernstrom-Lundberg C, Edstrom S, Bergstrom T. 1998 Tumor necrosis factor-alpha response and herpesvirus infection in Bell's palsy. Laryngoscope. 1998 Aug;108(8 Pt 1):1171-6. PMID: 9707238.
  186. Lekstrom-Himes JA, Pesnicak L, Straus SE. 1998. The quantity of latent viral DNA correlates with the relative rates at which herpes simplex virus types 1 and 2 cause recurrent genital herpes outbreaks. J Virol. 1998 Apr;72(4):2760-4. PMID: 9525595.
  187. Lekstrom-Himes JA, Wang K, Pesnicak L, Krause PR, Straus SE. 1998. The comparative biology of latent herpes simplex virus type 1 and type 2 infections: latency-associated transcript promoter activity and expression in vitro and in infected mice. J Neurovirol. 1998 Feb;4(1):27-37. PMID: 9531009.
  188. Levi M, Ruden U, Wahren B. 1996. Peptide sequences of glycoprotein G-2 discriminate between herpes simplex virus type 2 (HSV-2) and HSV-1 antibodies. Clin Diagn Lab Immunol. 1996 May;3(3):265-9. PMID: 8705666.
  189. Lewandowski G, Hobbs MV, Bloom FE. 1994. Alteration of intracerebral cytokine production in mice infected with herpes simplex virus types 1 and 2. J Neuroimmunol. 1994 Nov;55(1):23-34. PMID: 7962482.
  190. Liang GS, Daikos GL, Serfling U, Zhu WY, Pecoraro M, Leonardi CL, Fischl MA, Penneys NS. 1993. An evaluation of oral ulcers in patients with AIDS and AIDS-related complex. J Am Acad Dermatol. 1993 Oct;29(4):563-8. PMID: 8408791.
  191. Liljeqvist JA, Svennerholm B, Bergstrom T. 1999. Herpes simplex virus type 2 glycoprotein G-negative clinical isolates are generated by single frameshift mutations. J Virol. 1999 Dec;73(12):9796-802. PMID: 10559290. Docherty JJ, Fu MM, Stiffler BS, Limperos RJ, Pokabla CM, DeLucia AL. 1999. Resveratrol inhibition of herpes simplex virus replication. Antiviral Res. 1999 Oct;43(3):145-55. PMID: 10551373.
  192. Liljeqvist JA, Svennerholm B, Bergstrom T. 2000. Conservation of type-specific B-cell epitopes of glycoprotein G in clinical herpes simplex virus type 2 isolates. J Clin Microbiol. 2000 Dec;38(12):4517-22. PMID: 11101589.
  193. Liljeqvist JA, Trybala E, Svennerholm B, Jeansson S, Sjogren-Jansson E, Bergstrom T. 1998. Localization of type-specific epitopes of herpes simplex virus type 2 glycoprotein G recognized by human and mouse antibodies. J Gen Virol. 1998 May;79 ( Pt 5):1215-24. PMID: 9603337.
  194. Liu B, Sun J, Tao W. 1997. Detecting pathogens of fetal defects in paraffin embedded tissues by polymerase chain reaction]. Zhonghua Fu Chan Ke Za Zhi. 1997 Jul;32(7):412-4. Chinese. PMID: 9639727.
  195. Lortholary O, Rozenberg F, Perronne C, Djebbour S, Leport C, Vilde JL. 1993. Herpes simplex virus type 2 DNA in cerebrospinal fluid of a woman with recurrent meningitis. Clin Infect Dis. 1993 Nov;17(5):941-2. No abstract available. PMID: 8286655.
  196. Lowe DM, Alderton WK, Ellis MR, Parmar V, Miller WH, Roberts GB, Fyfe JA, Gaillard R, Ertl P, Snowden W, et al. 1995. Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses. Antimicrob Agents Chemother. 1995 Aug;39(8):1802-8. PMID: 7486922.
  197. Lucasson JF, McNab D, Collins TC, Mattingly JR, Keen JN, MacLean AB, MacNab 1994. JC. HSV-2 increases the mitochondrial aspartate amino transaminase characteristic of tumor cells. Virology. 1994 Dec;205(2):393-405. PMID: 7975243.
  198. Lulitanond V, Chantratita W, Thammaprasert K, Nimmanahaeminda K, 1994. Matangkasombut P, Yoosook C. Detection of herpes simplex virus type 2 Bgl II N fragment in paraffin-embedded cervical tissue sections using nested polymerase chain reaction. Mol Cell Probes. 1994 Dec;8(6):441-7. PMID: 7700264.
  199. Luo JH, Puc JA, Slosberg ED, Yao Y, Bruce JN, Wright TC Jr, Becich MJ, Parsons R. 1999. Differential subtraction chain, a method for identifying differences in genomic DNA and mRNA. Nucleic Acids Res. 1999 Oct 1;27(19):e24. PMID: 10481036.
  200. Lynas C, Hill TJ, Maitland NJ, Love S. 1993. Latent infection with the MS strain of herpes simplex virus type 2 in the mouse following intracerebral inoculation. J Neurol Sci. 1993 Dec 1;120(1):107-14. PMID: 8289071.
  201. Madeleine MM, Daling JR, Carter JJ, Wipf GC, Schwartz SM, McKnight B, 1997. Kurman RJ, Beckmann AM, Hagensee ME, Galloway DA. Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst. 1997 Oct 15;89(20):1516-23. PMID: 9337348.
  202. Madhavan HN, Priya K, Anand AR, Therese KL. 1999. Detection of herpes simplex virus (HSV) genome using polymerase chain reaction (PCR) in clinical samples comparison of PCR with standard laboratory methods for the detection of HSV. J Clin Virol. 1999 Oct;14(2):145-51. PMID: 10588457.
  203. Malmgaard L, Paludan SR, Mogensen SC, Ellermann-Eriksen S. 2000. Herpes simplex virus type 2 induces secretion of IL-12 by macrophages through a mechanism involving NF-kappaB. J Gen Virol. 2000 Dec;81 Pt 12:3011-20. PMID: 11086132.
  204. Manickan E, Francotte M, Kuklin N, Dewerchin M, Molitor C, Gheysen D, Slaoui M, Rouse BT. 1995. Vaccination with recombinant vaccinia viruses expressing ICP27 induces protective immunity against herpes simplex virus through CD4+ Th1+ T cells. J Virol. 1995 Aug;69(8):4711-6. PMID: 7609036.
  205. Manning WC, Paliard X, Zhou S, Pat Bland M, Lee AY, Hong K, Walker CM, 1997. Escobedo JA, Dwarki V. Genetic immunization with adeno-associated virus vectors expressing herpes simplex virus type 2 glycoproteins B and D. J Virol. 1997 Oct;71(10):7960-2. PMID: 9311887.
  206. Mariette X, Molina JM, Asli B, Brouet JC.1999. A patient with chronic lymphoid leukemia and recurrent necrotic herpetic lymphadenitis. Am J Med. 1999 Oct;107(4):403-4. No abstract available. PMID: 10527048.
  207. Markomichelakis NN, Barampouti F, Zafirakis P, Chalkiadakis I, Kouris T, 1999. Ekonomopoulos N. Retinal vasculitis with a frosted branch angiitis-like response due to herpes simplex virus type 2. Retina. 1999;19(5):455-7. No abstract available. PMID: 10546946.
  208. Markomichelakis NN, Zafirakis P, Karambogia-Karefillidi P, Drakoulis N, Vagiakou-Boudri E, Paterakis G, Apostolopoulos M. 2001. Herpes simplex virus type 2: a cause of acute retinal necrosis syndrome. Ocul Immunol Inflamm. 2001 Jun;9(2):103-9. PMID: 11449326.
  209. Markoulatos P, Fountoucidou P, Marinakis G, Krikelis V, Spyrou N, Vamvakopoulos N, Moncany ML. 1997. Clear detection and typing of herpes simplex virus types 1 and 2 by an indirect ELISA assay: comparison with three different combined methods--capture ELISA, restriction enzymes, and polymerase chain reaction. J Clin Lab Anal. 1997;11(3):146-53. PMID: 9138103.
  210. Marsden HS, MacAulay K, Murray J, Smith IW. 1998. Identification of an immunodominant sequential epitope in glycoprotein G of herpes simplex virus type 2 that is useful for serotype-specific diagnosis. J Med Virol. 1998 Sep;56(1):79-84. PMID: 9700637.
  211. Marshall DS, Linfert DR, Draghi A, McCarter YS, Tsongalis GJ. 2001. Identification of herpes simplex virus genital infection: comparison of a multiplex PCR assay and traditional viral isolation techniques. Mod Pathol. 2001 Mar;14(3):152-6. PMID: 11266519.
  212. Mason A, Sallie R, Perrillo R, Rayner A, Xu L, Dohner DE, Dehner M, Naoumov N, Gelb L, Saha B, O'Grady J, Williams R. 1996. Prevalence of herpesviridae and hepatitis B virus DNA in the liver of patients with non-A, non-B fulminant hepatic failure. Hepatology. 1996 Dec;24(6):1361-5. PMID: 8938162.
  213. Mastrolorenzo A, Tiradritti L, Salimbeni L, Zuccati G. 1995. Multicentre clinical trial with herpes simplex virus vaccine in recurrent herpes infection. Int J STD AIDS. 1995 Nov-Dec;6(6):431-5. PMID: 8845402.
  214. Mauri DN, Ebner R, Montgomery RI, Kochel KD, Cheung TC, Yu GL, Ruben S, Murphy M, Eisenberg RJ, Cohen GH, Spear PG, Ware CF. 1998. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity. 1998 Jan;8(1):21-30. PMID: 9462508.
  215. McClements WL, Armstrong ME, Keys RD, Liu MA. 1996. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease. Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11414-20. PMID: 8876149.
  216. McClements WL, Armstrong ME, Keys RD, Liu MA. 1997. The prophylactic effect of immunization with DNA encoding herpes simplex virus glycoproteins on HSV-induced disease in guinea pigs. Vaccine. 1997 Jun;15(8):857-60. PMID: 9234533.
  217. McDougall JK, Nelson JA, Myerson D, Beckmann AM, Galloway DA. 1984. HSV, CMV, and HPV in human neoplasia. J Invest Dermatol. 1984 Jul;83(1 Suppl):72s-76s. Review. PMID: 6330227.
  218. Meijer A, van der Vliet JA, Schouls LM, de Vries A, Roholl PJ, Ossewaarde 1998. JM. Detection of microorganisms in vessel wall specimens of the abdominal aorta: development of a PCR assay in the absence of a gold standard. Res Microbiol. 1998 Sep;149(8):577-83. PMID: 9795995.
  219. Mertens G, Ieven M, Ursi D, Pattyn SR, Martin JJ, Parizel PM. 1993. Detection of herpes simplex virus in the cerebrospinal fluid of patients with encephalitis using the polymerase chain reaction. J Neurol Sci. 1993 Sep;118(2):213-6. PMID: 8229072.
  220. Mietz H, Cassinotti P, Siegl G, Kirchhof B, Krieglstein GK. 1995. Detection of herpes simplex virus after penetrating keratoplasty by polymerase chain reaction: correlation of clinical and laboratory findings. Graefes Arch Clin Exp Ophthalmol. 1995 Nov;233(11):714-6. PMID: 8566829.
  221. Mikloska Z, Ruckholdt M, Ghadiminejad I, Dunckley H, Denis M, Cunningham AL. 2000. Monophosphoryl lipid A and QS21 increase CD8 T lymphocyte cytotoxicity to herpes simplex virus-2 infected cell proteins 4 and 27 through IFN-gamma and IL-12 production. J Immunol. 2000 May 15;164(10):5167-76. PMID: 10799875.
  222. Mindel A, Estcourt C. 1998. Public and personal health implications of asymptomatic viral shedding in genital herpes. Sex Transm Infect. 1998 Dec;74(6):387-9. No abstract available. PMID: 10195042.
  223. Minjolle S, Michelet C, Jusselin I, Joannes M, Cartier F, Colimon R. 1999. Amplification of the six major human herpesviruses from cerebrospinal fluid by a single PCR. J Clin Microbiol. 1999 Apr;37(4):950-3. PMID: 10074507.
  224. Mousavi-Jazi M, Bostrom L, Lovmark C, Linde A, Brytting M, Sundqvist VA. 1998.Infrequent detection of cytomegalovirus and Epstein-Barr virus DNA in synovial membrane of patients with rheumatoid arthritis. J Rheumatol. 1998 Apr;25(4):623-8. PMID: 9558160.
  225. Muggeridge MI. 2000. Characterization of cell-cell fusion mediated by herpes simplex virus 2 glycoproteins gB, gD, gH and gL in transfected cells. J Gen Virol. 2000 Aug;81 Pt 8:2017-27. PMID: 10900041.
  226. Murata T, Goshima F, Daikoku T, Takakuwa H, Nishiyama Y. 2000. Expression of herpes simplex virus type 2 US3 affects the Cdc42/Rac pathway and attenuates c-Jun N-terminal kinase activation. Genes Cells. 2000 Dec;5(12):1017-27. PMID: 11168588.
  227. Najioullah F, Bosshard S, Thouvenot D, Boibieux A, Menager B, Biron F, 2000. Aymard M, Lina B. Diagnosis and surveillance of herpes simplex virus infection of the central nervous system. J Med Virol. 2000 Aug;61(4):468-73. PMID: 10897065.
  228. Nakajima H, Furutama D, Kimura F, Shinoda K, Nakagawa T, Shimizu A, Ohsawa 1995. N. Herpes simplex virus type 2 infections presenting as brainstem encephalitis and recurrent myelitis. Intern Med. 1995 Sep;34(9):839-42. PMID: 8580553.
  229. Nakajima H, Furutama D, Shinoda K, Ohsawa N, Nakagawa T. 1993. Three cases of herpes simplex virus type 2 myelitis--detection of HSV2 DNA in cerebrospinal fluid. Rinsho Shinkeigaku. 1993 Jul;33(7):715-20. Japanese. PMID: 8252822.
  230. Nakao M, Hazama M, Mayumi-Aono A, Hinuma S, Fujisawa Y. 1994. Immunotherapy of acute and recurrent herpes simplex virus type 2 infection with an adjuvant-free form of recombinant glycoprotein D-interleukin-2 fusion protein. J Infect Dis. 1994 Apr;169(4):787-91. PMID: 8133093.
  231. Nakazato I, Kinjo T, Sirirungsi W, Tsuhako K, Miyagi J, Higa M, Iwamasa T. 2000. Experimental myelitis in BALB/cN and C57BL/6N mice caused by herpes simplex virus type 1 compared with herpes simplex virus type 2. Pathol Res Pract. 2000;196(9):635-45. PMID: 10997739.
  232. Nash KA, Klein JS, Inderlied CB. 1995. Internal controls as performance monitors and quantitative standards in the detection by polymerase chain reaction of herpes simplex virus and cytomegalovirus in clinical specimens. Mol Cell Probes. 1995 Oct;9(5):347-56. PMID: 8569776.
  233. Nesburn AB, Burke RL, Ghiasi H, Slanina S, Bahri S, Wechsler SL. 1994. Vaccine therapy for ocular herpes simplex virus (HSV) infection: periocular vaccination reduces spontaneous ocular HSV type 1 shedding in latently infected rabbits. J Virol. 1994 Aug;68(8):5084-92. PMID: 8035508.
  234. Nesburn AB, Burke RL, Ghiasi H, Slanina SM, Wechsler SL. 1998. A therapeutic vaccine that reduces recurrent herpes simplex virus type 1 corneal disease. Invest Ophthalmol Vis Sci. 1998 Jun;39(7):1163-70. PMID: 9620075.
  235. Nicola AV, Peng C, Lou H, Cohen GH, Eisenberg RJ. 1997. Antigenic structure of soluble herpes simplex virus (HSV) glycoprotein D correlates with inhibition of HSV infection. J Virol. 1997 Apr;71(4):2940-6. PMID: 9060653.
  236. Niwamoto H, Okamoto E, Fujimoto J, Takeuchi M, Furuyama J, Yamamoto Y. 1995. Are human herpes viruses or measles virus associated with esophageal achalasia? Dig Dis Sci. 1995 Apr;40(4):859-64. PMID: 7720482.
  237. Norais N, Tang D, Kaur S, Chamberlain SH, Masiarz FR, Burke RL, Marcus F. 1996. Disulfide bonds of herpes simplex virus type 2 glycoprotein gB. J Virol. 1996 Nov;70(11):7379-87. PMID: 8892856.
  238. Novak EJ, Liu AW, Gebe JA, Falk BA, Nepom GT, Koelle DM, Kwok WW. 2001. Tetramer-guided epitope mapping: rapid identification and characterization of immunodominant CD4+ T cell epitopes from complex antigens. J Immunol. 2001 Jun 1;166(11):6665-70. PMID: 11359821.
  239. O'Hagan D, Goldbeck C, Ugozzoli M, Ott G, Burke RL. 1999. Intranasal immunization with recombinant gD2 reduces disease severity and mortality following genital challenge with herpes simplex virus type 2 in guinea pigs. Vaccine. 1999 May 4;17(18):2229-36. PMID: 10403590.
  240. O'Keeffe RS, Johnston MD, Slater NK. 1999. The affinity adsorptive recovery of an infectious herpes simplex virus vaccine. Biotechnol Bioeng. 1999 Mar 5;62(5):537-45. PMID: 10099562.
  241. Obara Y, Furuta Y, Takasu T, Suzuki S, Suzuki H, Matsukawa S, Fujioka Y, 1997. Takahashi H, Kurata T, Nagashima K. Distribution of herpes simplex virus types 1 and 2 genomes in human spinal ganglia studied by PCR and in situ hybridization. J Med Virol. 1997 Jun;52(2):136-42. PMID: 9179758.
  242. Obara Y. 1994. Distribution of herpes simplex virus type 1 and 2 genomes in the human spinal ganglia. Hokkaido Igaku Zasshi. 1994 Sep;69(5):1132-9. Japanese. PMID: 7868053.
  243. Ohtani F, Furuta Y, Horal P, Bergstrom T. 2000. Rapid strip assay for detection of anti-herpes simplex virus antibodies: application to prediction of varicella-zoster virus reactivation in patients with acute peripheral facial palsy. J Med Virol. 2000 Sep;62(1):37-41. PMID: 10935986.
  244. Ono N, Iwayama S, Suzuki K, Sekiyama T, Nakazawa H, Tsuji T, Okunishi M, Daikoku T, Nishiyama Y. 1998. Mode of action of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl) cycloprop-1'-yl]methyl]guanine (A-5021) against herpes simplex virus type 1 and type 2 and varicella-zoster virus. Antimicrob Agents Chemother. 1998 Aug;42(8):2095-102. PMID: 9687413.
  245. Orle KA, Gates CA, Martin DH, Body BA, Weiss JB. 1996. Simultaneous PCR detection of Haemophilus ducreyi, Treponema pallidum, and herpes simplex virus types 1 and 2 from genital ulcers. J Clin Microbiol. 1996 Jan;34(1):49-54. PMID: 8748271.
  246. Oshima S, Daikoku T, Shibata S, Yamada H, Goshima F, Nishiyama Y. 1998. Characterization of the UL16 gene product of herpes simplex virus type 2. Arch Virol. 1998;143(5):863-80. PMID: 9645194.
  247. Oxford JS, al-Jabri AA, Stein CA, Levantis P. 1996. Analysis of resistance mutants of viral polymerases. Methods Enzymol. 1996;275:555-600. Review. No abstract available. PMID: 9026659.
  248. Oyan AM, Dolter KE, Langeland N, Goins WF, Glorioso JC, Haarr L, Crumpacker CS. 1993. Resistance of herpes simplex virus type 2 to neomycin maps to the N-terminal portion of glycoprotein C. J Virol. 1993 May;67(5):2434-41. PMID: 8386261.
  249. Ozaki N, Sugiura Y, Yamamoto M, Yokoya S, Wanaka A, Nishiyama Y. 1997. Apoptosis induced in the spinal cord and dorsal root ganglion by infection of herpes simplex virus type 2 in the mouse. Neurosci Lett. 1997 Jun 6;228(2):99-102. PMID: 9209108.
  250. Pachuk CJ, Arnold R, Herold K, Ciccarelli RB, Higgins TJ. 1998. Humoral and cellular immune responses to herpes simplex virus-2 glycoprotein D generated by facilitated DNA immunization of mice. Curr Top Microbiol Immunol. 1998;226:79-89. Review. No abstract available. PMID: 9479837.
  251. Paludan SR, Ellermann-Eriksen S, Lovmand J, Mogensen SC. 1999. Interleukin-4-mediated inhibition of nitric oxide production in interferon-gamma-treated and virus-infected macrophages. Scand J Immunol. 1999 Feb;49(2):169-76. PMID: 10075021.
  252. Paludan SR, Ellermann-Eriksen S, Malmgaard L, Mogensen SC. 2000. Herpes simplex virus type 2 infection of macrophages impairs IL-4-mediated inhibition of NO production through TNF-alpha-induced activation of NF-kappaB. Arch Virol. 2000;145(3):575-91. PMID: 10795524.
  253. Paludan SR. 2001. Requirements for the induction of interleukin-6 by herpes simplex virus-infected leukocytes. J Virol. 2001 Sep;75(17):8008-15. PMID: 11483745.
  254. Park M, Lonsdale DM, Timbury MC, Subak-Sharpe JH, Macnab JC. 1980. Genetic retrieval of viral genome sequences from herpes simplex virus transformed cells. Nature. 1980 Jun 5;285(5764):412-5. PMID: 6247659.
  255. Peng T, Hunter JR, Nelson JW. 1996. The novel protein kinase of the RR1 subunit of herpes simplex virus has autophosphorylation and transphosphorylation activity that differs in its ATP requirements for HSV-1 and HSV-2. Virology. 1996 Feb 1;216(1):184-96 PMID: 8614985.
  256. Perry JD, Girkin CA, Miller NR, Kerr DA. 1998. Herpes simplex encephalitis and bilateral acute retinal necrosis syndrome after craniotomy. Am J Ophthalmol. 1998 Sep;126(3):456-60. PMID: 9744385.
  257. Pevenstein SR, Williams RK, McChesney D, Mont EK, Smialek JE, Straus SE. 1999. Quantitation of latent varicella-zoster virus and herpes simplex virus genomes in human trigeminal ganglia. J Virol. 1999 Dec;73(12):10514-8. PMID: 10559370.
  258. Piiparinen H, Koskiniemi M, Vaheri A. 1995. Polymerase chain reaction assay of HSV in the rapid diagnosis of encephalitis. 1995. Duodecim. 1995;111(2):129-33. Finnish. No abstract available. PMID: 8654268.
  259. Piret J, Lamontagne J, Bestman-Smith J, Roy S, Gourde P, Desormeaux A, Omar RF, Juhasz J, Bergeron MG. 2000. In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency viruses. J Clin Microbiol. 2000 Jan;38(1):110-9. PMID: 10618073.
  260. Podlech J, Hengerer F, Fleck M, Kunkel J, Falke D. 1997. Localization of latency-associated transcripts in the uterovaginal plexus of herpes simplex virus type 1 and 2 latently infected mice. J Gen Virol. 1997 May;78 ( Pt 5):1103-8. PMID: 9152429.
  261. Podzorski RP, Baker J, Merline JR, Qureshi R, Holsinger JE. 2000. Utility of restriction fragment analysis for typing herpes simplex virus amplicons following PCR of targets in the DNA polymerase gene. Diagn Microbiol Infect Dis. 2000 Aug;37(4):289-91. PMID: 10974583.
  262. Posavad CM, Koelle DM, Corey L. 1998. Tipping the scales of herpes simplex virus reactivation: the important responses are local. Nat Med. 1998 Apr;4(4):381-2. Review. No abstract available. PMID: 9546773.
  263. Posavad CM, Rosenthal KL. 1992. Herpes simplex virus-infected human fibroblasts are resistant to and inhibit cytotoxic T-lymphocyte activity. J Virol. 1992 Nov;66(11):6264-72. PMID: 1328666.
  264. Purves FC, Spector D, Roizman B. 1991. The herpes simplex virus 1 protein kinase encoded by the US3 gene mediates posttranslational modification of the phosphoprotein encoded by the UL34 gene. J Virol. 1991 Nov;65(11):5757-64. PMID: 1656069.
  265. Raguin G, Malkin JE. 1997. Genital herpes: epidemiology and pathophysiology. Update and new perspectives. Ann Med Interne (Paris). 1997;148(8):530-3. Review. PMID: 9538399.
  266. Rahhal FM, Siegel LM, Russak V, Wiley CA, Tedder DG, Weinberg A, Rickman L, 1996. Freeman WR. Clinicopathologic correlations in acute retinal necrosis caused by herpes simplex virus type 2. Arch Ophthalmol. 1996 Nov;114(11):1416-9. PMID: 8906037.
  267. Ravi V, Kennedy PG, MacLean AR. 1998. Functional analysis of the herpes simplex virus type 2 strain HG52 RL1 gene: the intron plays no role in virulence. J Gen Virol. 1998 Jul;79 ( Pt 7):1613-7. PMID: 9680122.
  268. Read SJ, Kurtz JB. 1999. Laboratory diagnosis of common viral infections of the central nervous system by using a single multiplex PCR screening assay. J Clin Microbiol. 1999 May;37(5):1352-5. PMID: 10203485.
  269. Reichstetter S, Ettinger RA, Liu AW, Gebe JA, Nepom GT, Kwok WW. 2000. Distinct T cell interactions with HLA class II tetramers characterize a spectrum of TCR affinities in the human antigen-specific T cell response. J Immunol. 2000 Dec 15;165(12):6994-8. PMID: 11120826.
  270. Reichstetter S, Kwok WW, Kochik S, Koelle DM, Beaty JS, Nepom GT. 1999. MHC-peptide ligand interactions establish a functional threshold for antigen-specific T cell recognition. Hum Immunol. 1999 Jul;60(7):608-18. PMID: 10426278.
  271. Reyes GR, Jeang KT, Hayward GS. 1982. Transfection with the isolated herpes simplex virus thymidine kinase genes. I. Minimal size of the active fragments from HSV-1 and HSV-2. J Gen Virol. 1982 Oct;62 (Pt 2):191-206. PMID: 6292348.
  272. Reyes GR, McLane MW, Hayward GS. 1982. Transfection with the isolated herpes simplex virus thymidine kinase genes. II. Evidence for amplification of viral and adjacent cellular DNA sequences. J Gen Virol. 1982 Jun;60(Pt 2):209-24. PMID: 6286848.
  273. Roizman B, Markovitz N. 1997. Herpes simplex virus virulence: the functions of the gamma (1)34.5 gene. J Neurovirol. 1997 May;3 Suppl 1:S1-2. No abstract available. PMID: 9179780.
  274. Roizman B, Warren J, Thuning CA, Fanshaw MS, Norrild B, Meignier B. 1982. Application of molecular genetics to the design of live herpes simplex virus vaccines. Dev Biol Stand. 1982;52:287-304. PMID: 6299836.
  275. Rojas JM, Dopazo J, Santana M, Lopez-Galindez C, Tabares E.i1995. Comparative study of the genetic variability in thymidine kinase and glycoprotein B genes of herpes simplex viruses by the RNase A mismatch cleavage method. Virus Res. 1995 Feb;35(2):205-14. PMID: 7762293.
  276. Roller RJ, Roizman B. 1990. The herpes simplex virus Us11 open reading frame encodes a sequence-specific RNA-binding protein. J Virol. 1990 Jul;64(7):3463-70. PMID: 2161949.
  277. Rosen A, Darai G. 1985. Investigation of the virulence genes of herpes simplex virus 2 by experimental infection in vivo with defined intertypic recombinants of a virulent HSV-2 X an avirulent HSV-1. Med Microbiol Immunol (Berl). 1985;174(5):237-48. PMID: 3003551.
  278. Ruther U, Nunnensiek C, Muller HA, Bader H, May U, Jipp P. 1998. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease). Hepatogastroenterology. 1998 May-Jun;45(21):691-9. PMID: 9684118.
  279. Ryncarz AJ, Goddard J, Wald A, Huang ML, Roizman B, Corey L. 1999. Development of a high-throughput quantitative assay for detecting herpes simplex virus DNA in clinical samples. J Clin Microbiol. 1999 Jun;37(6):1941-7. PMID: 10325351.
  280. Sakaoka H, Kurita K, Gouro T, Kumamoto Y, Sawada S, Ihara M, Kawana T. 1995. Analysis of genomic polymorphism among herpes simplex virus type 2 isolates from four areas of Japan and three other countries. J Med Virol. 1995 Mar;45(3):259-72. PMID: 7775947.
  281. Sanna PP, Williamson RA, De Logu A, Bloom FE, Burton DR. 1995. Directed selection of recombinant human monoclonal antibodies to herpes simplex virus glycoproteins from phage display libraries. Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6439-43. PMID: 7604009.
  282. Sarisky RT, Quail MR, Clark PE, Nguyen TT, Halsey WS, Wittrock RJ, O'Leary 2001. Bartus J, Van Horn MM, Sathe GM, Van Horn S, Kelly MD, Bacon TH, Leary JJ. Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir. J Virol. 2001 Feb;75(4):1761-9. PMID: 11160674.
  283. Sasadeusz JJ, Sacks SL. 1996. Spontaneous reactivation of thymidine kinase-deficient, acyclovir-resistant type-2 herpes simplex virus: masked heterogeneity or reversion? J Infect Dis. 1996 Sep;174(3):476-82. PMID: 8769603.
  284. Sauerbrei A, Eichhorn U, Hottenrott G, Wutzler P. 2000. Virological diagnosis of herpes simplex encephalitis. J Clin Virol. 2000 Jun;17(1):31-6. PMID: 10814936.
  285. Schalasta G, Arents A, Schmid M, Braun RW, Enders G. 2000. Fast and type-specific analysis of herpes simplex virus types 1 and 2 by rapid PCR and fluorescence melting-curve-analysis. Infection. 2000 Mar-Apr;28(2):85-91. PMID: 10782393.
  286. Scheffer AJ, Koedijk DG, Abee T, Osterhaus AD. 1984. Monoclonal antibodies against herpes simplex viruses. Dev Biol Stand. 1984;57:269-74. PMID: 6098497.
  287. Schlesinger Y, Buller RS, Brunstrom JE, Moran CJ, Storch GA. 1996. Expanded spectrum of herpes simplex encephalitis in childhood. J Pediatr. 1995 Feb;126(2):234-41. PMID: 7844669.
  288. Schlesinger Y, Tebas P, Gaudreault-Keener M, Buller RS, Storch GA. 1995. Herpes simplex virus type 2 meningitis in the absence of genital lesions: improved recognition with use of the polymerase chain reaction. Clin Infect Dis. 1995 Apr;20(4):842-8. PMID: 7795083.
  289. Schlingemann RO, Bruinenberg M, Wertheim-van Dillen P, Feron E. 1996. Twenty years' delay of fellow eye involvement in herpes simplex virus type 2-associated bilateral acute retinal necrosis syndrome. Am J Ophthalmol. 1996 Dec;122(6):891-2. PMID: 8956648.
  290. Schmid DS, Brown DR, Nisenbaum R, Burke RL, Alexander D, Ashley R, Pellett PE, Reeves WC. 1999. Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2. J Clin Microbiol. 1999 Feb;37(2):376-9. PMID: 9889222.
  291. Scott DA, Coulter WA, Lamey PJ. 1997. Oral shedding of herpes simplex virus type 1: a review. J Oral Pathol Med. 1997 Nov;26(10):441-7. Review. PMID: 9416573.
  292. Scurry J, Wells M. 1992. Viruses in anogenital cancer. Epithelial Cell Biol. 1992 Jul;1(3):138-45. Review. PMID: 1339181.
  293. Seidel-Dugan C, Ponce de Leon M, Friedman HM, Fries LF, Frank MM, Cohen GH, Eisenberg RJ. 1988. C3b receptor activity on transfected cells expressing glycoprotein C of herpes simplex virus types 1 and 2. J Virol. 1988 Nov;62(11):4027-36. PMID: 2845122.
  294. Shiba C, Daikoku T, Goshima F, Takakuwa H, Yamauchi Y, Koiwai O, Nishiyama Y. 2000. The UL34 gene product of herpes simplex virus type 2 is a tail-anchored type II membrane protein that is significant for virus envelopment. J Gen Virol. 2000 Oct;81 Pt 10:2397-405. PMID: 10993927.
  295. Shoji H, Koga M, Kusuhara T, Kaji M, Ayabe M, Hino H, Hondo R. 1994. Differentiation of herpes simplex virus 1 and 2 in cerebrospinal fluid of patients with HSV encephalitis and meningitis by stringent hybridization of PCR-amplified DNAs. J Neurol. 1994 Aug;241(9):526-30. PMID: 7799000.
  296. Shukla D, Rowe CL, Dong Y, Racaniello VR, Spear PG. 1999. The murine homolog (Mph) of human herpesvirus entry protein B (HveB) mediates entry of pseudorabies virus but not herpes simplex virus types 1 and 2. J Virol. 1999 May;73(5):4493-7. PMID: 10196354.
  297. Sifakis S, Koumantakis E, Koffa M, Ergazaki M, Spandidos DA. 1998. Detection of herpes simplex virus (HSV) in aborted material using the polymerase chain reaction technique. Gynecol Obstet Invest. 1998;45(2):109-15. PMID: 9517803.
  298. Sin JI, Ayyavoo V, Boyer J, Kim J, Ciccarelli RB, Weiner DB. 1999. Protective immune correlates can segregate by vaccine type in a murine herpes model system. Int Immunol. 1999 Nov;11(11):1763-73. PMID: 10545480.
  299. Sin JI, Kim J, Pachuk C, Weiner DB. 2000. Interleukin 7 can enhance antigen-specific cytotoxic-T-lymphocyte and/or Th2-type immune responses in vivo. Clin Diagn Lab Immunol. 2000 Sep;7(5):751-8. PMID: 10973449.
  300. Sin JI, Kim JJ, Arnold RL, Shroff KE, McCallus D, Pachuk C, McElhiney SP, 1999. Wolf MW, Pompa-de Bruin SJ, Higgins TJ, Ciccarelli RB, Weiner DB. IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge. J Immunol. 1999 Mar 1;162(5):2912-21. PMID: 10072541.
  301. Sin JI, Kim JJ, Ugen KE, Ciccarelli RB, Higgins TJ, Weiner DB. 1998. Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes. Eur J Immunol. 1998 Nov;28(11):3530-40. PMID: 9842896.
  302. Singh M, Carlson JR, Briones M, Ugozzoli M, Kazzaz J, Barackman J, Ott G, 1998. O'Hagan D. A comparison of biodegradable microparticles and MF59 as systemic adjuvants for recombinant gD from HSV-2. Vaccine. 1998 Nov;16(19):1822-7. PMID: 9795387.
  303. Singh SP, Odze RD. 1998. Multinucleated epithelial giant cell changes in esophagitis: a clinicopathologic study of 14 cases. Am J Surg Pathol. 1998 Jan;22(1):93-9. PMID: 9422321.
  304. Sirirungsi W, Sunagawa K, Iwamasa T. 1995. Restriction endonuclease cleavage analysis of herpes simplex virus type 2 from Chiang Mai, Thailand and Okinawa, Japan. Trop Med Parasitol. 1995 Mar;46(1):1-5. PMID: 7631121.
  305. Slavkin HC. 1996 Infection and immunity. J Am Dent Assoc. 1996 Dec;127(12):1792-6. No abstract available. PMID: 8990752.
  306. Smith CC, Kulka M, Aurelian L. 2000. Modified adenovirus penton base protein (UTARVE) as a non-replicating vector for delivery of antisense oligonucleotides with antiviral and/or antineoplastic activity. Int J Oncol. 2000 Oct;17(4):841-50. PMID: 10995900.
  307. Smith CC, Luo JH, Hunter JC, Ordonez JV, Aurelian L. 1994. The transmembrane domain of the large subunit of HSV-2 ribonucleotide reductase (ICP10) is required for protein kinase activity and transformation-related signaling pathways that result in ras activation. Virology. 1994 May 1;200(2):598-612. PMID: 8178446.
  308. Smith CC, Peng T, Kulka M, Aurelian L. 1998. The PK domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is required for immediate-early gene expression and virus growth. J Virol. 1998 Nov;72(11):9131-41. PMID: 9765459.
  309. Smith JW. 1983. Herpes simplex virus. An expanding relationship to human cancer. J Reprod Med. 1983 Feb;28(2):116-22. Review. PMID: 6300393.
  310. Smith TJ, Ackland-Berglund CE, Leib DA. 2000. Herpes simplex virus virion host shutoff (vhs) activity alters periocular disease in mice. J Virol. 2000 Apr;74(8):3598-604. PMID: 10729135.
  311. Snoeck R, Andrei G, Gerard M, Silverman A, Hedderman A, Balzarini J, Sadzot-Delvaux C, Tricot G, Clumeck N, De Clercq E. 1994. Successful treatment of progressive mucocutaneous infection due to acyclovir-and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC). Clin Infect Dis. 1994 Apr;18(4):570-8. PMID: 8038312.
  312. Spector FC, Kern ER, Palmer J, Kaiwar R, Cha TA, Brown P, Spaete RR. 1998. Evaluation of a live attenuated recombinant virus RAV 9395 as a herpes simplex virus type 2 vaccine in guinea pigs. J Infect Dis. 1998 May;177(5):1143-54. PMID: 9592996.
  313. Stanberry LR, Burke R, Myers MG. 1988. Herpes simplex virus glycoprotein treatment of recurrent genital herpes. J Infect Dis. 1988 Jan;157(1):156-63. PMID: 2826603.
  314. Stanberry LR, Harrison CJ, Bernstein DI, Burke RL, Shukla R, Ott G, Myers MG. 1989. Herpes simplex virus glycoprotein immunotherapy of recurrent genital herpes: factors influencing efficacy. Antiviral Res. 1989 May-Jun;11(4):203-14. PMID: 2545166.
  315. Stanberry LR. 1994. The concept of immune-based therapies in chronic viral infections. J Acquir Immune Defic Syndr. 1994;7 Suppl 1:S1-5. Review. PMID: 8182508.
  316. Stanberry LR. 1998. Herpes. Vaccines for HSV. Dermatol Clin. 1998 Oct;16(4):811-6, xiv. Review. PMID: 9891686.
  317. Standring-Cox R, Bacon TH, Howard BA. 1996. Comparison of a DNA probe assay with the plaque reduction assay for measuring the sensitivity of herpes simplex virus and varicella-zoster virus to penciclovir and acyclovir. J Virol Methods. 1996 Jan;56(1):3-11. PMID: 8690764.
  318. Steffy KR, Schoen S, Chen CM. 1995. Nucleotide sequence of the herpes simplex virus type 2 gene encoding the protease and capsid protein ICP35. J Gen Virol. 1995 Apr;76 ( Pt 4):1069-72. PMID: 9049360.
  319. Stewart JF, Croxson MC, Powell KF, Polkinghorne PJ. 1993. Identification of cytomegalovirus in vitreous using the polymerase chain reaction. Aust N Z J Ophthalmol. 1993 Aug;21(3):165-9. PMID: 8260155.
  320. Straus SE, Corey L, Burke RL, Savarese B, Barnum G, Krause PR, Kost RG, 1994. Meier JL, Sekulovich R, Adair SF, et al. Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes. Lancet. 1994 Jun 11;343(8911):1460-3. PMID: 7911177.
  321. Straus SE, Wald A, Kost RG, McKenzie R, Langenberg AG, Hohman P, Lekstrom J, Cox E, Nakamura M, Sekulovich R, Izu A, Dekker C, Corey L. 1997. Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: results of a placebo-controlled vaccine trial. J Infect Dis. 1997 Nov;176(5):1129-34. PMID: 9359709.
  322. Stroop WG, Banks MC, Qavi H, Chodosh J, Brown SM. 1994. A thymidine kinase deficient HSV-2 strain causes acute keratitis and establishes trigeminal ganglionic latency, but poorly reactivates in vivo. J Med Virol. 1994 Jul;43(3):297-309. PMID: 7931192.
  323. Studahl M, Hagberg L, Rekabdar E, Bergstrom T. 2000. Herpesvirus DNA detection in cerebral spinal fluid: differences in clinical presentation between alpha-, beta-, and gamma-herpesviruses. Scand J Infect Dis. 2000;32(3):237-48. PMID: 10879592.
  324. Subramanian G, LeBlanc RA, Wardley RC, Fuller AO. 1995. Defective entry of herpes simplex virus types 1 and 2 into porcine cells and lack of infection in infant pigs indicate species tropism. J Gen Virol. 1995 Sep;76 ( Pt 9):2375-9. PMID: 7561780.
  325. Sucato G, Wald A, Wakabayashi E, Vieira J, Corey L. 1998. Evidence of latency and reactivation of both herpes simplex virus (HSV)-1 and HSV-2 in the genital region. J Infect Dis. 1998 Apr;177(4):1069-72. PMID: 9534984.
  326. Sunagawa K, Sirirungsi W, Nakazato I, Hirayasu T, Iwamasa T. 1995. Pathologic studies and comparison of the virulence of herpes simplex virus type 2 from Okinawa, Japan and Chiang Mai, Thailand. Int J Exp Pathol. 1995 Aug;76(4):255-62. PMID: 7547439.
  327. Suzutani T, Saijo M, Nagamine M, Ogasawara M, Azuma M. 2000. Rapid phenotypic characterization method for herpes simplex virus and Varicella-Zoster virus thymidine kinases to screen for acyclovir-resistant viral infection. J Clin Microbiol. 2000 May;38(5):1839-44. PMID: 10790110.
  328. Tachedjian G, Hoy J, McGavin K, Birch C. 1994. Long-term foscarnet therapy not associated with the development of foscarnet-resistant human immunodeficiency virus type 1 in an acquired immunodeficiency syndrome patient. J Med Virol. 1994 Feb;42(2):207-11. PMID: 7512615.
  329. Tang J. 1993. Molecular epidemiologic investigation on HSV infection among married women at childbearing age. Zhonghua Liu Xing Bing Xue Za Zhi. 1993 Aug;14(4):223-6. Chinese. PMID: 8143322.
  330. Tang YW, Cleavinger PJ, Li H, Mitchell PS, Smith TF, Persing DH.2000. Analysis of candidate-host immunogenetic determinants in herpes simplex virus-associated Mollaret's meningitis. Clin Infect Dis. 2000 Jan;30(1):176-8. PMID: 10619748.
  331. Terhune SS, Coleman KT, Sekulovich R, Burke RL, Spear PG. 1998. Limited variability of glycoprotein gene sequences and neutralizing targets in herpes simplex virus type 2 isolates and stability on passage in cell culture. J Infect Dis. 1998 Jul;178(1):8-15. PMID: 9652417.
  332. Thomas SK, Gough G, Latchman DS, Coffin RS. 1999. Herpes simplex virus latency-associated transcript encodes a protein which greatly enhances virus growth, can compensate for deficiencies in immediate-early gene expression, and is likely to function during reactivation from virus latency. J Virol. 1999 Aug;73(8):6618-25. PMID: 10400759.
  333. Thompson WS, Culbertson WW, Smiddy WE, Robertson JE, Rosenbaum JT. 1994. Acute retinal necrosis caused by reactivation of herpes simplex virus type 2. Am J Ophthalmol. 1994 Aug 15;118(2):205-11. PMID: 8053466.
  334. Thouvenot D, Najioullah F. 1999. Herpes simplex virus types 1 and 2 (HSV-1 and HSV-2). Rev Prat. 1999 Dec 15;49(20):2203-7. French. PMID: 10731803.
  335. Tigges MA, Leng S, Johnson DC, Burke RL. 1996. Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled. J Immunol. 1996 May 15;156(10):3901-10. PMID: 8621929.
  336. Tognon M, Cattozzo EM, Bianchi S, Romanelli MG. 1996. Enhancement of HSV-DNA infectivity, in Vero and RS cells, by a modified calcium-phosphate transfection technique. Virus Genes. 1996;12(2):193-7. PMID: 8879137.
  337. Tomazin R, van Schoot NE, Goldsmith K, Jugovic P, Sempe P, Fruh K, Johnson DC. 1998. Herpes simplex virus type 2 ICP47 inhibits human TAP but not mouse TAP. J Virol. 1998 Mar;72(3):2560-3. PMID: 9499125.
  338. Tremblay C, Coutlee F, Weiss J, Guibinga GH, Hankins C, Lapointe N. 1997. Evaluation of a non-isotopic polymerase chain reaction assay for detection in clinical specimens of herpes simplex virus type 2 DNA. Canadian Women's HIV Study Group. Clin Diagn Virol. 1997 May;8(1):53-62. PMID: 9248658.
  339. Trybala E, Liljeqvist JA, Svennerholm B, Bergstrom T. 2000. Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate. J Virol. 2000 Oct;74(19):9106-14. PMID: 10982357.
  340. Usui N, Kashiwase M, Minoda H, Yamauchi Y, Sakai J, Usui M, Sata T, Kurata 2000. T. [Typing of herpes simplex virus in patients with uveitis]. Nippon Ganka Gakkai Zasshi. 2000 Jul;104(7):476-82. Japanese. PMID: 10934865.
  341. van Gelderen BE, Van der Lelij A, Treffers WF, van der Gaag R. 2000. Detection of herpes simplex virus type 1, 2 and varicella zoster virus DNA in recipient corneal buttons. Br J Ophthalmol. 2000 Nov;84(11):1238-43. PMID: 11049947.
  342. Vecchione A, Cermele C, Giovagnoli MR, Valli C, Alimandi M, Carico E, Esposito DL, Mariani-Costantini R, French D. 1994. p53 expression and genetic evidence for viral infection in intraepithelial neoplasia of the uterine cervix. Gynecol Oncol. 1994 Dec;55(3 Pt 1):343-8. PMID: 7835772.
  343. Vel'tishcheva EI, Viduta OD, Ponomareva AM, Karakhan NM, Nisan LG, Dement'eva NM, Aleshkin VA. 1993. The primary immune response and virus-specific and -nonspecific immune complexes in neonatal cytomegalovirus and herpetic infection]. Zh Mikrobiol Epidemiol Immunobiol. 1993 Nov-Dec;(6):104-5. Russian. No abstract available. PMID: 8079522.
  344. Venot C, Beby A, Bourgoin A, Giraudeau G, Becq-Giraudon B, Agius G. 1998. Genital recurrent infection occurring 6 months after meningitis due to the same herpes simplex virus type 2 (HSV-2) strain evidence by restriction endonuclease analysis. J Infect. 1998 Mar;36(2):233-5. PMID: 9570665.
  345. Verjans GM, Remeijer L, Mooy CM, Osterhaus AD. 2000. Herpes simplex virus-specific T cells infiltrate the cornea of patients with herpetic stromal keratitis: no evidence for autoreactive T cells. Invest Ophthalmol Vis Sci. 2000 Aug;41(9):2607-12. PMID: 10937573.
  346. Vesanen M, Piiparinen H, Kallio A, Vaheri A. 1996. Detection of herpes simplex virus DNA in cerebrospinal fluid samples using the polymerase chain reaction and microplate hybridization. J Virol Methods. 1996 May;59(1-2):1-11. PMID: 8793825.
  347. Vogel JU, Weber B, Doerr HW. 1994. Typing and strain differentiation of clinical herpes simplex virus type 1 and 2 isolates by polymerase chain reaction and subsequent restriction fragment length polymorphism analysis. Zentralbl Bakteriol. 1994 Nov;281(4):502-12. PMID: 7727898.
  348. Voss JH, Roizman B. 1988. Properties of two 5'-coterminal RNAs transcribed part way and across the S component origin of DNA synthesis of the herpes simplex virus 1 genome. Proc Natl Acad Sci U S A. 1988 Nov;85(22):8454-8. PMID: 2847162.
  349. Wada K, Goshima F, Takakuwa H, Yamada H, Daikoku T, Nishiyama Y. 1999. Identification and characterization of the UL14 gene product of herpes simplex virus type 2. J Gen Virol. 1999 Sep;80 ( Pt 9):2423-31. PMID: 10501497.
  350. Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J. 1997. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J Clin Invest. 1997 Mar 1;99(5):1092-7. PMID: 9062368.
  351. Wald A, Matson P, Ryncarz A, Corey L. 1999. Detection of herpes simplex virus DNA in semen of men with genital HSV-2 infection. Sex Transm Dis. 1999 Jan;26(1):1-3. PMID: 9918316.
  352. Wald A, Zeh J, Selke S, Warren T, Ryncarz AJ, Ashley R, Krieger JN, Corey L. 2000. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med. 2000 Mar 23;342(12):844-50. PMID: 10727588.
  353. Wang JY, Montone KT. 1994. A rapid simple in situ hybridization method for herpes simplex virus employing a synthetic biotin-labeled oligonucleotide probe: a comparison with immunohistochemical methods for HSV detection. J Clin Lab Anal. 1994;8(2):105-15. PMID: 8189321.
  354. Wang K, Krause PR, Straus SE. 1995. Analysis of the promoter and cis-acting elements regulating expression of herpes simplex virus type 2 latency-associated transcripts. J Virol. 1995 May;69(5):2873-80. PMID: 7707511.
  355. Wang K, Pesnicak L, Guancial E, Krause PR, Straus SE. 2001. The 2.2-kilobase latency-associated transcript of herpes simplex virus type 2 does not modulate viral replication, reactivation, or establishment of latency in transgenic mice. J Virol. 2001 Sep;75(17):8166-72. PMID: 11483762.
  356. Wang K, Pesnicak L, Straus SE. 1997. Mutations in the 5' end of the herpes simplex virus type 2 latency-associated transcript (LAT) promoter affect LAT expression in vivo but not the rate of spontaneous reactivation of genital herpes. J Virol. 1997 Oct;71(10):7903-10. PMID: 9311880.
  357. Wang Y, Liu P, Yu S. 1994. Epidemiological study on risk factors of cervical cancer. Zhonghua Liu Xing Bing Xue Za Zhi. 1994 Apr;15(2):103-6. Chinese. PMID: 7923330.
  358. Watanabe D, Ushijima Y, Goshima F, Takakuwa H, Tomita Y, Nishiyama Y. 2000. Identification of nuclear export signal in UL37 protein of herpes simplex virus type 2. Biochem Biophys Res Commun. 2000 Oct 5;276(3):1248-54. PMID: 11027618.
  359. Watkins AM, Dunford PJ, Moffatt AM, Wong-Kai-In P, Holland MJ, Pole DS, 1998. Thomas GM, Martin J, Roberts NA, Mulqueen MJ. Inhibition of virus-encoded thymidine kinase suppresses herpes simplex virus replication in vitro and in vivo. Antivir Chem Chemother. 1998 Jan;9(1):9-18. PMID: 9875372.
  360. Whaley KJ, Zeitlin L, Barratt RA, Hoen TE, Cone RA. 1994. Passive immunization of the vagina protects mice against vaginal transmission of genital herpes infections. J Infect Dis. 1994 Mar;169(3):647-9. PMID: 8158042.
  361. Whittington WL, Celum CL, Cent A, Ashley RL. 2001. Use of a glycoprotein G-based type-specific assay to detect antibodies to herpes simplex virus type 2 among persons attending sexually transmitted disease clinics. Sex Transm Dis. 2001 Feb;28(2):99-104. PMID: 11234793.
  362. Williams RK, Straus SE. 1997. Specificity and affinity of binding of herpes simplex virus type 2 glycoprotein B to glycosaminoglycans. J Virol. 1997 Feb;71(2):1375-80. PMID: 8995662.
  363. Wright CA, Haffajee Z, van Iddekinge B, Cooper K. 1995. Detection of herpes simplex virus DNA in spontaneous abortions from HIV-positive women using non-isotopic in situ hybridization. J Pathol. 1995 Aug;176(4):399-402. PMID: 7562255.
  364. Yamada H, Jiang YM, Oshima S, Daikoku T, Yamashita Y, Tsurumi T, Nishiyama Y. 1998. Characterization of the UL55 gene product of herpes simplex virus type 2. J Gen Virol. 1998 Aug;79 ( Pt 8):1989-95. PMID: 9714248.
  365. Yamada H, Jiang YM, Oshima S, Wada K, Goshima F, Daikoku T, Nishiyama Y. 1998. Characterization of the UL4 gene product of herpes simplex virus type 2. Arch Virol. 1998;143(6):1199-207. PMID: 9687876.
  366. Yamada H, Jiang YM, Zhu HY, Inagaki-Ohara K, Nishiyama Y. 1999. Nucleolar localization of the UL3 protein of herpes simplex virus type 2. J Gen Virol. 1999 Aug;80 ( Pt 8):2157-64. PMID: 10466815.
  367. Yamaguchi T, Yamashita Y, Kasamo K, Inoue M, Sakaoka H, Fujinaga K. 1998. Genomic heterogeneity maps to tandem repeat sequences in the herpes simplex virus type 2 UL region. Virus Res. 1998 Jun;55(2):221-31. PMID: 9725674.
  368. Yamakawa Y, Forslund O, Chua KL, Dillner L, Boon ME, Hansson BG. 1994. Detection of the BC 24 transforming fragment of the herpes simplex virus type 2 (HSV-2) DNA in cervical carcinoma tissue by polymerase chain reaction (PCR). APMIS. 1994 Jun;102(6):401-6. PMID: 7794306.
  369. Yamamoto T, Nakamura Y. 2000. A single tube PCR assay for simultaneous amplification of HSV-1/-2, VZV, CMV, HHV-6A/-6B, and EBV DNAs in cerebrospinal fluid from patients with virus-related neurological diseases. J Neurovirol. 2000 Oct;6(5):410-7. PMID: 11031694.
  370. Yamauchi Y, Shiba C, Goshima F, Nawa A, Murata T, Nishiyama Y. 2001. Herpes simplex virus type 2 UL34 protein requires UL31 protein for its relocation to the internal nuclear membrane in transfected cells. J Gen Virol. 2001 Jun;82(Pt 6):1423-8. PMID: 11369887.
  371. Yamauchi Y, Wada K, Goshima F, Takakuwa H, Daikoku T, Yamada M, Nishiyama Y. 2001. The UL14 protein of herpes simplex virus type 2 translocates the minor capsid protein VP26 and the DNA cleavage and packaging UL33 protein into the nucleus of coexpressing cells. J Gen Virol. 2001 Feb;82(Pt 2):321-30. PMID: 11161269.
  372. Yang H, Li M, Jiang Y. 1997. Molecular cloning and sequence analysis of glycoprotein D gene of herpes simplex virus 2 strain Sav and wild strain isolated. Zhonghua Yi Xue Za Zhi. 1997 Feb;77(2):97-9. Chinese. PMID: 9596937.
  373. Yoosook C, Bhattarakosol P, Wilairat P, Sriurairatna S. 1994. Encapsidation defectiveness of herpes simplex virus type 2 during replication at acid pH condition. Asian Pac J Allergy Immunol. 1994 Jun;12(1):59-64. PMID: 7872993.
  374. York LJ, Giorgio DP, Mishkin EM. 1995. Immunomodulatory effects of HSV2 glycoprotein D in HSV1 infected mice: implications for immunotherapy of recurrent HSV infection. Vaccine. 1995 Dec;13(17):1706-12. PMID: 8719523.
  375. Yoshikawa T, Hill JM, Stanberry LR, Bourne N, Kurawadwala JF, Krause PR. 1996. The characteristic site-specific reactivation phenotypes of HSV-1 and HSV-2 depend upon the latency-associated transcript region. J Exp Med. 1996 Aug 1;184(2):659-64. PMID: 8760819.
  376. Yoshikawa T, Stanberry LR, Bourne N, Krause PR. 1996. Downstream regulatory elements increase acute and latent herpes simplex virus type 2 latency-associated transcript expression but do not influence recurrence phenotype or establishment of latency. J Virol. 1996 Mar;70(3):1535-41. PMID: 8627672.
  377. Zheng B, Graham FL, Johnson DC, Hanke T, McDermott MR, Prevec L. 1993. Immunogenicity in mice of tandem repeats of an epitope from herpes simplex gD protein when expressed by recombinant adenovirus vectors. Vaccine. 1993 Sep;11(12):1191-8. PMID: 7504857.
  378. Zhu HY, Yamada H, Jiang YM, Yamada M, Nishiyama Y. 1999. Intracellular localization of the UL31 protein of herpes simplex virus type 2. Arch Virol. 1999;144(10):1923-35. PMID: 10550666.
  379. Zhu J, Aurelian L. 1997. AP-1 cis-response elements are involved in basal expression and Vmw110 transactivation of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10). Virology. 1997 May 12;231(2):301-12. PMID: 9168892.
  380. Zvonarev AI, Shatalin KI, Klichko VI, Karaseva EV, Kuliakina MN. 1994. The production of recombinant polypeptides from the herpes simplex viruses types 1 and 2. Vopr Virusol. 1994 May-Jun;39(3):110-3. Russian. PMID: 8091748.